Special Article
Is the Placebo Powerless? — An Analysis of Clinical Trials Comparing Placebo with No Treatment
N Engl J Med 2001; 344:1594-1602May 24, 2001
- Abstract
Background
Placebo treatments have been reported to help patients with many diseases, but the quality of the evidence supporting this finding has not been rigorously evaluated.
Methods
We conducted a systematic review of clinical trials in which patients were randomly assigned to either placebo or no treatment. A placebo could be pharmacologic (e.g., a tablet), physical (e.g., a manipulation), or psychological (e.g., a conversation).
Results
We identified 130 trials that met our inclusion criteria. After the exclusion of 16 trials without relevant data on outcomes, there were 32 with binary outcomes (involving 3795 patients, with a median of 51 patients per trial) and 82 with continuous outcomes (involving 4730 patients, with a median of 27 patients per trial). As compared with no treatment, placebo had no significant effect on binary outcomes, regardless of whether these outcomes were subjective or objective. For the trials with continuous outcomes, placebo had a beneficial effect, but the effect decreased with increasing sample size, indicating a possible bias related to the effects of small trials. The pooled standardized mean difference was significant for the trials with subjective outcomes but not for those with objective outcomes. In 27 trials involving the treatment of pain, placebo had a beneficial effect, as indicated by a reduction in the intensity of pain of 6.5 mm on a 100-mm visual-analogue scale.
Conclusions
We found little evidence in general that placebos had powerful clinical effects. Although placebos had no significant effects on objective or binary outcomes, they had possible small benefits in studies with continuous subjective outcomes and for the treatment of pain. Outside the setting of clinical trials, there is no justification for the use of placebos.
Media in This Article
Table 1
Effect of Placebo in Trials with Binary or Continuous Outcomes.Table 2
Effect of Placebo on Specific Clinical Problems.Article Activity
- Article
Placebos have been reported to improve subjective and objective outcomes in up to 30 to 40 percent of patients with a wide range of clinical conditions, such as pain, asthma, high blood pressure, and even myocardial infarction.1-3 In his 1955 article “The Powerful Placebo,” Beecher concluded, “It is evident that placebos have a high degree of therapeutic effectiveness in treating subjective responses, decided improvement, interpreted under the unknowns technique as a real therapeutic effect, being produced in 35.2±2.2% of cases.”1
Beecher's article and the 35 percent figure are often cited as evidence that a placebo can be an important medical treatment. The vast majority of reports on placebos, including Beecher's article, have estimated the effect of placebo as the difference from base line in the condition of patients in the placebo group of a randomized trial after treatment. With this approach, the effect of placebo cannot be distinguished from the natural course of the disease, regression to the mean, and the effects of other factors.4-6 The reported large effects of placebo could therefore, at least in part, be artifacts of inadequate research methods.
Despite the reservations of many physicians,7 the clinical use of placebo has been advocated in editorials and articles in leading journals.3,8,9 To understand better the effects of placebo as a treatment, we conducted a systematic review of clinical trials in which patients with various clinical conditions were randomly assigned to placebo or to no treatment. We were primarily interested in the clinical effect of placebo as a treatment for disease, rather than the role of placebo as a comparison treatment in clinical trials. A secondary aim was to study whether the effect of placebo differed for subjective and objective outcomes.
Methods
Definition of Placebo
Placebo is difficult to define satisfactorily.5 In clinical trials, placebos are generally control treatments with a similar appearance to the study treatments but without their specific activity. We therefore defined placebo practically as an intervention labeled as such in the report of a clinical trial.
Literature Search
We searched Medline, EMBASE, PsycLIT, Biological Abstracts, and the Cochrane Controlled Trials Register for trials published before the end of 1998. The search was developed iteratively for synonyms of “placebo,” “no treatment,” and “randomized clinical trial” (the exact search strategy is available as Supplementary Appendix 1 with the full text of this article at http://www.nejm.org and was based on a published protocol10). We systematically read the reference lists of included trials and selected books and review articles. We also asked researchers in the field to provide lists of relevant trials.
Selection of Studies
We included studies if patients were assigned randomly to a placebo group or an untreated group (often there was also a third group that received active treatment). We excluded studies if randomization was clearly not concealed — that is, if group assignment were predictable11 (e.g., patients were assigned to treatment groups according to the day of the month). We also excluded studies if participants were paid or were healthy volunteers, if the person who assessed objective outcomes was aware of group assignments, if the dropout rate exceeded 50 percent, or if it was very likely that the alleged placebo had a clinical effect not associated with the treatment ritual alone (e.g., movement techniques for postoperative pain). All potentially eligible trial reports were read in full by both authors. Disagreements concerning eligibility were resolved by discussion.
Extraction of Data
Data were extracted from the report of each trial with the use of forms tested in pilot studies. We contacted the authors of the included studies when reported outcome data were inadequate for meta-analysis. We noted how the randomization was conducted and whether the therapist responsible for the administration of placebo (as distinct from the observer) was unaware of group assignments. Furthermore, we noted the purpose of the trial, the dropout rate, whether the placebo was given in addition to the standard treatment, and whether the main outcome was clearly indicated.
We noted whether the placebo was pharmacologic (e.g., a tablet), physical (e.g., a manipulation), or psychological (e.g., a conversation); whether clinical problems reported by the patients could have been observed by others (i.e., whether the symptoms were observable outcomes such as cough); and whether objective outcomes were laboratory data, were derived from examinations that required the cooperation of the patients (i.e., objective outcomes such as forced expiratory volume), or did not require such cooperation (e.g., edema).
Both reviewers independently selected outcomes by referring only to the methods sections of articles; any disagreements were resolved by discussion. As the primary outcome, we selected the main objective or subjective outcome of each trial (preferably a characteristic symptom). If a main outcome was not indicated, we used the outcome that we felt was most relevant to patients. Binary outcomes (e.g., the proportions of smokers and nonsmokers) were preferred to continuous ones (e.g., the mean number of cigarettes smoked). Data recorded immediately after the end of treatment were preferred to follow-up data, although end-of-treatment data were not always available. For crossover trials, we extracted data from the first treatment period only; if that was not possible, we used the summary data as if they had been derived from a parallel-group trial (i.e., using the between-group standard deviations and total number of participants for both groups).
Synthesis of Data
For each trial with binary outcomes, we calculated the relative risk of an unwanted outcome, defined as the ratio of the number of patients with an unwanted outcome to the total number of patients in the placebo group, divided by the same ratio in the untreated group. Thus, a relative risk below 1.0 indicates a beneficial effect of placebo.
For trials with continuous outcomes, we calculated the standardized mean difference, which was defined as the difference between the mean value for an unwanted outcome in the placebo group and the corresponding mean value in the untreated group divided by the pooled standard deviation.12 A value of –1 signifies that the mean in the placebo group was 1 SD below the mean in the untreated group, indicating a beneficial effect of placebo.
We calculated the pooled relative risk of an unwanted outcome for trials with binary outcomes and the pooled standardized mean difference for those with continuous outcomes.13 Because of the different clinical conditions and settings, we expected that the data sets would be heterogeneous — that is, that the effects of individual trials would vary more than expected by chance alone. The variance and statistical significance of the differences were therefore assessed with the use of random-effect calculations.13 We calculated the pooled effects for subjective and objective outcomes and for specific clinical problems that had been investigated in at least three trials by different research groups.14
We performed preplanned analyses of subgroups to see whether our findings were sensitive to the type of placebo or the type of outcome involved. Furthermore, for each trial, we plotted the effect against the inverse of its standard error (which increases with the number of trial participants). Since the variation in the estimated effect decreases with increasing sample size, the plot is expected to resemble a symmetrical funnel. If there is significant asymmetry in such funnel plots, it is usually caused by small trials' reporting greater effects, on average, than large trials, which can reflect publication bias15 or other biases. We also performed several preplanned sensitivity analyses to determine whether our findings were sensitive to variations in the quality of the trials.
In trials with continuous outcomes, we used F tests to check whether the standard deviations of the placebo group and the untreated group were significantly different.16 We regarded the distributions of either group as non-Gaussian if 1.64 SD exceeded the mean for positive outcomes.17 Chi-square tests were used to test for heterogeneity on the basis of the DerSimonian and Laird Q statistic.13,18 Results are reported with 95 percent confidence intervals. All P values are two-tailed.
Results
Selection and Characteristics of Studies
We identified 727 potentially eligible trials. We subsequently excluded 597 trials for the following reasons: 404 were nonclinical or nonrandomized, 129 were missing a placebo group or an untreated group, 29 were reported in more than one publication, 11 had clearly unblinded assessment of objective outcomes, and 24 met other criteria for exclusion, such as dropout rates over 50 percent. No relevant outcome data were available for 16 of the remaining 130 trials. The analysis therefore included 114 trials.19-132
There were 10 crossover trials, of which 7 (which included a total of 182 patients) were handled as parallel trials. In 112 trials, there was a third group assigned to active treatment in addition to the placebo and the untreated groups. In 88 of these, determining the effect of placebo was not mentioned as an objective of the study. The trial reports were published in five languages between 1946 and 1998. The outcomes were binary in 32 trials19-50 and continuous in 82.51-132 In 76 trials, the outcome in the data we extracted was identified as a main outcome by the authors of the trials. If only patients in the placebo and untreated groups were counted, the trials with binary outcomes included 3795 patients with a median of 51 patients per trial (interquartile range, 26 to 72), and the trials with continuous outcomes included 4730 patients with a median of 27 patients per trial (interquartile range, 20 to 52).
The typical pharmacologic placebo was a lactose tablet. The typical physical placebo was a procedure performed with a machine that was turned off (e.g., sham transcutaneous electrical nerve stimulation). The typical psychological placebo was a nondirectional, neutral discussion between the patient and the treatment provider, referred to as an “attention placebo.” No treatment typically entailed observation only or standard therapy; in the latter case, all patients in the trial received standard therapy, and the placebo was additional.
The results for the individual trials are available as Supplementary Appendix 2
Supplementary Appendix 2. Trials with Binary Outcomes. and Supplementary Appendix 3
Supplementary Appendix 3. Trials with Continuous Outcomes. with the full text of this article at http://www.nejm.org. The trials investigated 40 clinical conditions: hypertension, asthma, anemia, hyperglycemia, hypercholesterolemia, seasickness, Raynaud's disease, alcohol abuse, smoking, obesity, poor oral hygiene, herpes simplex infection, bacterial infection, common cold, pain, nausea, ileus, infertility, cervical dilatation, labor, menopause, prostatism, depression, schizophrenia, insomnia, anxiety, phobia, compulsive nail biting, mental handicap, marital discord, stress related to dental treatment, orgasmic difficulties, fecal soiling, enuresis, epilepsy, Parkinson's disease, Alzheimer's disease, attention-deficit–hyperactivity disorder, carpal tunnel syndrome, and undiagnosed ailments.Binary Outcomes
As compared with no treatment, placebo did not have a significant effect on binary outcomes (overall pooled relative risk of an unwanted outcome with placebo, 0.95; 95 percent confidence interval, 0.88 to 1.02). The pooled relative risk was 0.95 for trials with subjective outcomes (95 percent confidence interval, 0.86 to 1.05) and 0.91 for trials with objective outcomes (95 percent confidence interval, 0.80 to 1.04) (Table 1Table 1
Effect of Placebo in Trials with Binary or Continuous Outcomes.).There was significant heterogeneity among the trials with binary outcomes (P=0.003), indicating that the variation in the effect of placebo among trials was larger than would be expected to result from chance alone. The heterogeneity was not due to small trials' showing more pronounced effects of placebo than large trials (P=0.56).15
Three clinical problems had been investigated in at least three independent trials with binary outcomes: nausea, relapse after the cessation of smoking, and depression. Placebo had no significant effect on these outcomes, but the confidence intervals were wide (Table 2Table 2
Effect of Placebo on Specific Clinical Problems.).Continuous Outcomes
The overall pooled standardized mean difference was –0.28 (95 percent confidence interval, –0.38 to –0.19). Thus, there was a beneficial effect of placebo, because the pooled mean of the placebo groups was 0.28 SD lower than the pooled mean of the untreated groups (P<0.001). The pooled standardized mean difference was significant for trials with subjective outcomes (–0.36; 95 percent confidence interval, –0.47 to –0.25) but not for trials with objective outcomes (–0.12; 95 percent confidence interval, –0.27 to 0.03) (Table 1).
There was significant heterogeneity among the trials with continuous outcomes (P<0.001). The magnitude of the effect of placebo decreased with increasing sample size (P=0.05), indicating a possible bias related to the effects of small trials.
Pain, obesity, asthma, hypertension, insomnia, and anxiety were each investigated in at least three independent trials. Only the 27 trials involving the treatment of pain (including a total of 1602 patients) showed a significant effect of placebo as compared with no treatment (pooled standardized mean difference, –0.27; 95 percent confidence interval, –0.40 to –0.15). There was no significant effect of placebo on the other conditions, although the confidence intervals were wide (Table 2).
Expressing the standardized mean differences in terms of clinical outcomes indicates that the effect of placebo on pain corresponds to a reduction in the mean intensity of pain of 6.5 mm (95 percent confidence interval, 3.6 to 9.6) on a 100-mm visual-analogue scale. The nonsignificant effect of placebo on obesity corresponds to a reduction in mean weight of 3.2 percent (95 percent confidence interval, 7.4 to –1.2 percent); on hypertension, a reduction in mean diastolic blood pressure of 3.2 mm Hg (95 percent confidence interval, 7.8 to –1.3); and on insomnia, a decrease in the mean time required to fall asleep of 10 minutes (95 percent confidence interval, 25 to –5). For asthma and anxiety, the measurement scales were too variable to allow clinical interpretation of the results.
Small trials involving the treatment of pain did not have significantly greater effects than large trials (P=0.20), but the power of the test was low.15 There was no significant heterogeneity among the nine sets of data on specific clinical problems (P>0.10), but the power of these analyses was also low.
Sensitivity Analyses
The number of trials compared in the sensitivity analyses was in most cases nine or more, and they included more than 1000 patients. There was no difference in the effect of placebo between subcategories of objective and subjective binary outcomes (Table 3Table 3
Effect of Placebo in Trials with Specific Types of Outcomes.). The effect of placebo among subcategories of continuous outcomes did not differ significantly, except for a negative effect of placebo in four trials with laboratory data66,67,75,76 (Table 3). For both continuous and binary outcomes, there were no significant differences among the various types of placebos (Table 4Table 4
Effect of Three Types of Placebo.).The effect of placebo on continuous or binary outcomes was not influenced by the dropout rate (≤ 15 percent vs. > 15 percent) or by whether the observers were aware of group assignments, but only two trials with binary objective outcomes (involving 316 patients) included observers who were clearly unaware of the group assignments39,40 (data not shown). The effects of placebo were also unrelated to whether the care providers were unaware of the treatment type (placebo or experimental), whether placebos were given in addition to standard treatments, whether the effect of placebo was an explicit research objective, or whether we had identified the main outcome on the basis of clinical relevance (data not shown). The size of the effect in trials with clearly concealed randomization did not differ from that in other trials, but only four trials with continuous outcomes84,95,97,107 (involving 523 patients) and one with binary outcomes40 (involving 54 patients) reported clearly concealed randomization (data not shown). For continuous outcomes, the effect was not influenced by non-Gaussian distributions in the placebo or the untreated groups (data not shown).
Discussion
We did not detect a significant effect of placebo as compared with no treatment in pooled data from trials with subjective or objective binary or continuous objective outcomes. We did, however, find a significant difference between placebo and no treatment in trials with continuous subjective outcomes and in trials involving the treatment of pain.
Several types of bias may have affected our findings. Blinded evaluation of subjective outcomes was not possible in the trials we reviewed. Patients in an untreated group would know they were not being treated, and patients in a placebo group would think they had received treatment. It is difficult to distinguish between reporting bias and a true effect of placebo on subjective outcomes, since a patient may tend to try to please the investigator and report improvement when none has occurred. The fact that placebos had no significant effect on objective continuous outcomes suggests that reporting bias may have been a factor in the trials with subjective outcomes.
If patients in the untreated groups sought treatment outside the trials more often than patients in the placebo groups, the effects of placebo might be less apparent. Very few trials provided information on concomitant treatment. The risk of bias is expected to be larger in trials in which placebo is the only treatment and is not given in addition to standard therapy. We did not, however, find a difference in effect between the two types of trials.
There was some evidence that placebos had greater effects in small trials with continuous outcomes than in large trials. This could indicate that some small trials with negative outcomes have not been published or that we did not identify them.15 It is difficult to identify relevant trials in this field; another systematic search for trials involving placebo groups versus untreated groups found only 12 studies.133 We identified 114 trials from which the outcomes could be extracted, but 88 of these trials investigated the effect of active treatment in a third group of patients and did not explicitly study the effect of placebo. Because the publication of such trials is not directly associated with the effect of placebo, it is unlikely that the existence of unpublished trials could explain the higher effects reported in small studies.
Poor methodology in small trials could also explain the large effects of placebo. It surprised us that we found no association between measures of the quality of a trial and placebo effects. However, the statistical power of our sensitivity analyses may have been too low. Furthermore, it is possible that small trials tended to investigate clinical conditions in which placebos truly had greater effects. Thus, although we found an effect of placebos on subjective continuous outcomes, the inverse relation between trial size and effect size implies that the estimates of pooled effect should be interpreted cautiously.
It can also be difficult to interpret whether a pooled standardized mean difference is large enough to be clinically meaningful. Some individual trials reported clinically relevant effects with standardized mean differences of less than –0.6,91 but such “outlier” values may be spurious. If the possible biases we have discussed are disregarded, the pooled effect of placebo on pain corresponds to one third of the effect of nonsteroidal antiinflammatory drugs, as compared with placebo, in double-blind trials.134 It is uncertain whether such an effect is important for patients.
Our study has other limitations. We did extensive analyses of predefined subgroups according to the type of placebo, disease, and outcome without identifying a subgroup of trials in which the effect of placebo was large. However, we cannot exclude the possibility that, in the pooling of heterogeneous trials, the existence of such a subgroup was obscured. Our conclusions are also limited to the clinical conditions and outcomes that were investigated. It should be noted that few trials reported on the quality of life or patients' well-being.
We reviewed the effect of placebos but not the effect of the patient–provider relationship. We could not rule out a psychological therapeutic effect of this relationship, which may be largely independent of any placebo intervention.20
Moreover, the use of placebos in blinded, randomized trials is a precaution directed against many forms of bias and not only a way of controlling for the effects of placebo. Patients who are aware of their treatment assignment may differ from unaware patients in their way of reporting beneficial and harmful effects of treatment, in their tendency to seek additional treatment outside the study, and in their risk of dropping out of the study. Furthermore, staff members who are aware of treatment assignments may differ in their use of alternative forms of care and in their assessment of outcomes. Thus, even if there was no true effect of placebo, one would expect to find differences between placebo and untreated groups because of bias associated with a lack of double-blinding.
We were unable to detect any such significant difference in trials with subjective or objective binary or continuous objective outcomes. This surprising finding can possibly be explained by our selection of trials. Since our goal was to study the clinical effect of placebos, we reduced the influence of observer bias and bias due to dropouts by excluding trials with clearly unblinded objective outcomes and by attempting to analyze post-treatment data instead of follow-up data. In addition, since most trials we included did not primarily address the effect of a placebo but, rather, evaluated that of an active treatment, our study may have underestimated bias associated with the interests of the investigators. Since the design of our review precludes estimation of the overall influence of bias due to a lack of double-blinding, our results do not imply that control groups that receive no treatment can be substituted for control groups that receive placebo without creating a risk of bias. This result is in accordance with an empirical study of 33 meta-analyses, which found that randomized trials that were not double-blinded yielded larger estimates than blinded trials, with odds ratios that were exaggerated by 17 percent.11
In conclusion, we found little evidence that placebos in general have powerful clinical effects. Placebos had no significant pooled effect on subjective or objective binary or continuous objective outcomes. We found significant effects of placebo on continuous subjective outcomes and for the treatment of pain but also bias related to larger effects in small trials. The use of placebo outside the aegis of a controlled, properly designed clinical trial cannot be recommended.
Supported by a grant from the Faculty of Health Sciences at the University of Copenhagen.
We are indebted to Henrik R. Wulff, Jos Kleijnen, and Iain Chalmers for valuable comments on previous versions of the manuscript; to Gunvor Kienle, Andrew Vickers, Harald Walach, Clive Adams, and Iain Chalmers for lists of relevant trials; and to the numerous placebo-trial researchers for access to additional data.
Source Information
From the Department of Medical Philosophy and Clinical Theory, University of Copenhagen, Panum Institute, and the Nordic Cochrane Centre, Rigshospitalet — both in Copenhagen, Denmark.
Address reprint requests to Dr. Hróbjartsson at the Department of Medical Philosophy and Clinical Theory, University of Copenhagen, Panum Institute, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark, or at a.hrobjartsson@cochrane.dk.
Appendix
Supplementary Appendix 1. Search Strategy
Medline, EMBASE, PsycLIT, Biological Abstracts, and the Cochrane Controlled Trials Register were searched.
Search history for Medline Advanced SilverPlatter version, from 1966 to 1998
PLACEBO* for MOCK* or SHAM* or FAKE* or VEHICLE* or DUMM* or ATTENTION* CONTROL* or PSEUDO* TREAT* or UN?SPECIFIC* or NON?SPECIFIC*
and
NO??TREAT* or NO TREAT* or NON TREAT* or UN?TREAT* or UN TREAT* or MINIM* TREAT* or USUAL?TREAT* or USUAL TREAT* or
NO INTERV* or NON INTERV* or NO??INTERV* or NO CONTACT* OR NON CONTACT* or NO??CONTACT?* or USUAL CONTACT* OR USUAL CARE* or
NO PILL* or NON PILL* or NO??PILL* or NO TABLET* or NON TABLET* or NO??TABLET* or NO MEDIC* or NON MEDIC* or NO??MEDIC* or UN MEDIC* or UN?MEDIC* or MINIM* MEDIC* or
NO??SURGER* or NO OPERAT* or NON OPERAT* or NO??OPERAT* OR NO SURGER* OR NON SURGER* OR NO??SURGER* or
(NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in AB or (NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in T1
WAITING LIST* or WAITING?LIST* or ((NATURAL or SPONTANEOUS) NEAR1 (COURSE or DEVELOPMENT or HISTORY)) or
((TWO or “2” or THREE or “3” or FOUR or “4” or FIVE or “5” or SIX or “6” or SEVEN or “7”) NEAR1 (GROUPS or TREATMENT GROUPS)) NEAR (CONTROL or CONTROLS)
and
DOUBLE-BLIND-METHOD or SINGLE-BLIND-METHOD or RANDOM-ALLOCATION or RANDOMIZED-CONTROLLED-TRIALS/ALL SUBHEADINGS or CLINICAL-TRIALS/ALL SUBHEADINGS or
(CLINICAL-TRIAL or RANDOMIZED-CONTROLLED-TRIAL or CONTROLLED-CLINICAL-TRIAL) in PT or
RANDOM* or (CLINICAL near TRIAL*) or DOUBLE* BLIND* or SINGLE* BLIND*
and
HUMAN in TG
Comment:
The central search term “no” was initially an unsearchable stop word in Medline. With the help of the staff at Radcliffe Science Library in Oxford in the United Kingdom, we contacted the National Library of Medicine in the United States and the status of “no” was changed to that of a normal search word.
Search strategy for EMBASE CD SilverPlatter version, from 1980 to 1998
PLACEBO* or MOCK* or SHAM* or FAKE* or VEHICLE* or DUMM* or ATTENTION* CONTROL* or PSEUDO* TREAT* OR UN?specific* or NON?SPECIFIC*
and
NO??TREAT* or NO TREAT* or NON TREAT* or UN?TREAT* or UN TREAT* or MINIM* TREAT* or USUAL?TREAT* or USUAL TREAT* or WITHOUT TREAT* or WITHOUT?TREAT* or
NO INTERV* or NON INTERV* or NO??INTERV* or NO CONTACT* OR NON CONTACT* or NO??CONTACT* or USUAL CONTACT*or USUAL CARE* or
(NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in AB or (NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in T1 or
NO PILL* or NON PILL* or NO??PILL* or NO TABLET* or NON TABLET* or NO??TABLET* or
WAITING LIST* or WAITING?LIST* or ((NATURAL or SPONTANEOUS) NEAR1 (COURSE or DEVELOPMENT or HISTORY)) or
NO MEDIC* or NON MEDIC* or NO??MEDIC* or UN MEDIC* or UN?MEDIC* or MINIM* MEDIC* or
NO OPERAT* or NON OPERAT* or NO??OPERAT* or NO SURGER* or NON SURGER* or NO??SURGER* or
((TWO or “2” or THREE or “3” or FOUR or “4” or FIVE or “5” or SIX or “6” or SEVEN or “7”) NEAR1 (GROUPS or TREATMENT GROUPS)) NEAR (CONTROL or CONTROLS)
and
CLINICAL-TRIAL or RANDOMIZED-CONTROLLED-TRIAL or RANDOMIZATION or DOUBLE-BLIND-PROCEDURE or SINGLE-BLIND-PROCEDURE or CONTROLLED-STUDY or MAJOR-CLINICAL-STUDY or CLINICAL-ARTICLE or
RANDOM* or (CLINICAL near TRIAL*) or DOUBLE* BLIND* or SINGLE* BLIND*
and
HUMAN- in DE
Search Strategy for PsycLIT SilverPlatter version up to 1998
PLACEBO* or MOCK* or SHAM* or FAKE* or VEHICLE* or DUMM* or PSEUDO* TREAT* or ATTENTION* CONTROL* OR UNSPECIFIC* OR NON?SPECIFIC*
and
NO??TREAT* or NO TREAT* or NON TREAT* or UN?TREAT* or UN TREAT* or MINIM* TREAT* or WITHOUT TREAT* or
NO??INTERV* or NO INTERV* OR NON INTERV* or UN?INTERV* or UN INTERV* or MINIM* INTERV* or WITHOUT INTERV* or
NO??MEDIC* or NO MEDIC* or NON MEDIC* or UN?MEDIC* or UN MEDIC* or MINIM* MEDIC* or WITHOUT MEDIC* or NO??PILL* or NO PILL* or NON PILL* or
NO??OPERAT* or NO OPERAT* or NON OPERAT* or UN?OPERAT* or UN OPERAT* or MINIM* OPERAT* or WITHOUT OPERAT* or NO??SURGER* or NO SURGER* or NON SURGER* or MINIM* SURGER* or WITHOUT SURGER* or
WAITING?LIST* or WAITING LIST or VISITATION* or ((NATURAL or SPONTANEOUS) NEAR1 (COURSE* or DEVELOPMENT* or HISTORY*)) or
((TWO or “2” or THREE or “3” or FOUR or “4” or FIVE or “5” or SIX or “6” or SEVEN or “7”) NEAR1 (GROUPS or TREATMENT GROUPS)) NEAR (CONTROL or CONTROLS)
and
not ANIMAL in (PO or DE)
Comment:
Neither the indexation of clinical trials nor the reporting in abstracts in PsycLIT was helpful for the reliable identification of randomized trials. With the purpose of minimizing the number of missed randomized trials, any search terms aimed at identifying clinical trials were omitted. In a later filtering process, abstracts were read in full.
Search strategy for Biological Abstracts on CD SilverPlatter version, from 1986 to 1998
PLACEBO* or MOCK* or SHAM* or FAKE* or VEHICLE* or DUMM* or ATTENTION* CONTROL* or PSEUDO* CONTROL* or UN?SPECIFIC* or NON?SPECIFIC*
and
NO??TREAT* or NO TREAT* or NON TREAT* or UN?TREAT* or UN TREAT* or MINIM* TREAT* or USUAL?TREAT* or USUAL TREAT* or WITHOUT TREAT* or WITHOUT?TREAT* or
NO INTERV* or NON INTERV* or NO??INTERV* or NO CONTACT* or NON CONTACT* or NO??CONTACT?* or
NO CONTACT* or NON CONTACT* or NO??CONTACT* or USUAL CONTACT* or USUAL CARE* or
NO PILL* or NON PILL* or NO??PILL or NO TABLET* or NON TABLET* or NO??TABLET* or
(NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in TI or
(NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in AB or
NO MEDIC* or NON MEDIC* or NO??MEDIC* or UN MEDIC* or UN?MEDIC* or MINIM* MEDIC* or
NO OPERAT* or NON OPERAT* or NO??OPERAT* or NO SURGER* or NON SURGER* or NO??SURGER* or
WAITING LIST* or WAITING?LIST* or ((NATURAL or SPONTANEOUS) NEAR1 (COURSE or DEVELOPMENT or HISTORY)) or
((TWO or “2” or THREE or “3” or FOUR or “4” or FIVE or “5” or SIX or “6” or SEVEN or “7”) NEAR1 (GROUPS or TREATMENT GROUPS)) NEAR (CONTROL or CONTROLS)
and
RANDOM* or (CLINICAL near TRIAL*) or DOUBLE* BLIND* or SINGLE* BLIND*
and
HUMAN- in OR or HUMAN in DE or HUMANS in ST
Search Strategy for Cochrane Controlled Trials Register version 1998/3
PLACEBO* or MOCK* or SHAM* or FAKE* or VEHICLE* or DUMM* or ATTENTION*CONTROL* or PSEUDO*TREAT* or UN?SPECIFIC* or NON?SPECIFIC*
and
not (MEDLINE or EMBASE)
References were downloaded to a ProCite file. A second search was conducted in ProCite with a simplified search strategy based on “no treatment” expressions:
“no treat*” or “no-treat*” or “non treat*” or “non-treat*” or “untreat*” or “no interv*” or “no-interv*” or “non interv*” or “non-interv*” or “no contact*” or “no-contact*” or “non contact*” or “non-contact*” or “usual care*” or “no tablet*” or “no-tablet*” or “non tablet*” or “non-tablet*” or “no pill*” or “no-pill*” or “non pill*” or “non-pill*” or “waiting list*” or “waitinglist*” or “waiting-list*” or “natural course” or “natural development” or “natural history” or “spontaneous course” or “spontaneous development” or “spontaneous history” or “no medic*” or “non medic*” or “non-medic*” or “no surger” or “non surger*” or “non-surger*” or “no operat*” or “non operat*” or “non-operat*”
Comment:
It was not possible to search for words containing less than three letters in the Cochrane Controlled Trials Register. This made searches for the essential term “no” impossible. The two-phase search strategy described above was therefore implemented.
- References
References
1
Beecher HK . The powerful placebo. JAMA 1955;159:1602-1606
Web of Science | Medline2
Lasagna L . The placebo effect. J Allergy Clin Immunol 1986;78:161-165
CrossRef | Web of Science | Medline3
Brown WA . The placebo effect. Sci Am 1998;278:90-95
CrossRef | Web of Science | Medline4
Kienle GS ,Kiene H . The powerful placebo effect: fact or fiction? J Clin Epidemiol 1997;50:1311-1318
CrossRef | Web of Science | Medline5
Gotzsche PC . Is there logic in the placebo? Lancet 1994;344:925-926
CrossRef | Web of Science | Medline6
Hrobjartsson A . The uncontrollable placebo effect. Eur J Clin Pharmacol 1996;50:345-348
CrossRef | Web of Science | Medline7
Rawlinson MC. Truth-telling and paternalism in the clinic: philosophical reflections on the use of placebos in medical practice. In: White L, Tursky B, Schwartz GE, eds. Placebo: theory, research, and mechanisms. New York: Guilford Press, 1985:403-18.
8
Oh VMS . The placebo effect: can we use it better? BMJ 1994;309:69-70
CrossRef | Web of Science | Medline9
Chaput de Saintonge DM ,Herxheimer A . Harnessing placebo effects in health care. Lancet 1994;344:995-998
CrossRef | Web of Science | Medline10
Hróbjartsson A, Gøtzsche PC. Placebo intervention compared with no treatment (protocol for a Cochrane review). In: The Cochrane library. No. 1. Oxford, England: Update Software, 1999 (software).
11
Schulz KF ,Chalmers I ,Hayes R ,Altman DG . Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412
CrossRef | Web of Science | Medline12
Estimation of a single effect size: parametric and nonparametric methods. In: Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando, Fla.: Academic Press, 1985:75-106.
13
DerSimonian R ,Laird N . Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188
CrossRef | Medline14
Linde K ,Clausius N ,Ramirez G , et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997;350:834-843[Erratum, Lancet 1998;351:220.]
CrossRef | Web of Science | Medline15
Egger M ,Davey Smith G ,Schneider M ,Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634
CrossRef | Web of Science | Medline16
Comparing groups — continuous data. In: Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991:179-228.
17
Cochrane Consumers & Communication Group. Statistical policy. In: The Cochrane library. No. 1. Oxford, England: Update Software, 1999 (software).
18
Comparing groups — categorical data. In: Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991:229-76.
19
Tyler DB . The influence of a placebo, body position and medication on motion sickness. Am J Physiol 1946;146:458-466
Web of Science | Medline20
Thomas KB . General practice consultations: is there any point in being positive? BMJ 1987;294:1200-1202
CrossRef | Web of Science | Medline21
Hutton N ,Wilson MH ,Mellits D , et al. Effectiveness of an antihistamine-decongestant combination for young children with the common cold: a randomized, controlled clinical trial. J Pediatr 1991;118:125-130
CrossRef | Web of Science | Medline22
Guglielmi RS ,Roberts AH ,Patterson R . Skin temperature biofeedback for Raynaud's disease: a double-blind study. Biofeedback Self Regul 1982;7:99-120
CrossRef | Medline23
Watzl H ,Olbrich R ,Rist F ,Cohen R . Placebo-Injektionen und Alkoholkontrollen in der stationären Behandlung alkoholkranker Frauen -- eine experimentelle Untersuchung Zweier Behandlungsmerkmale. Z Klin Psychol 1986;15:333-34524
Wilson A ,Davidson WJ ,Blanchard R . Disulfiram implantation: a trial using placebo implants and two types of controls. J Stud Alcohol 1980;41:429-436
Web of Science | Medline25
Killen JD ,Fortmann SP ,Newman B ,Varady A . Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 1990;58:85-92
CrossRef | Web of Science | Medline26
Malcolm RE ,Sillett RW ,Turner JAM ,Ball KP . The use of nicotine chewing gum as an aid to stopping smoking. Psychopharmacology (Berl) 1980;70:295-296
CrossRef | Web of Science | Medline27
Jacobs MA ,Spilken AZ ,Norman MM ,Wohlberg GW ,Knapp PH . Interaction of personality and treatment conditions associated with success in a smoking control program. Psychosom Med 1971;33:545-556
Web of Science | Medline28
Williams JM ,Hall DW . Use of single session hypnosis for smoking cessation. Addict Behav 1988;13:205-208
CrossRef | Web of Science | Medline29
Hyman GJ ,Stanley RO ,Burrows GD ,Horne DJ . Treatment effectiveness of hypnosis and behaviour therapy in smoking cessation: a methodological refinement. Addict Behav 1986;11:355-365
CrossRef | Web of Science | Medline30
Elliott CH ,Denney DR . A multiple-component treatment approach to smoking reduction. J Consult Clin Psychol 1978;46:1330-1339
CrossRef | Web of Science | Medline31
Faas A ,Chavannes AW ,van Eijk JTM ,Gubbels JW . A randomized, placebo-controlled trial of exercise therapy in patients with acute low back pain. Spine 1993;18:1388-1395
Web of Science | Medline32
Walton RE ,Chiappinelli J . Prophylactic penicillin: effect on posttreatment symptoms following root canal treatment of asymptomatic periapical pathosis. J Endod 1993;19:466-470
CrossRef | Web of Science | Medline33
McMillan CM . Transcutaneous electrical stimulation of Neiguan anti-emetic acupuncture point in controlling sickness following opioid analgesia in major orthopaedic surgery. Physiotherapy 1994;80:5-9
CrossRef34
Najningier B ,Patowski W ,Zieniewicz K , et al. Zofran w zapobieganiu nudnosciom i wymiotom po cholecystektomii laparoskopowej. Acta Endosc Pol 1997;7:125-12835
Dundee JW ,Chestnutt WN ,Ghaly RG ,Lynas AGA . Traditional Chinese acupuncture: a potentially useful antiemetic? BMJ 1986;293:583-584
CrossRef | Web of Science | Medline36
Adriaanse AH ,Kollee LAA ,Muytjens HL ,Nijhuis JG ,de Haan AFJ ,Eskes TKAB . Randomized study of vaginal chlorhexidine disinfection during labor to prevent vertical transmission of group B streptococci. Eur J Obstet Gynecol Reprod Biol 1995;61:135-141
CrossRef | Web of Science | Medline37
Harrison RF ,de Louvois J ,Blades M ,Hurley R . Doxycycline treatment and human infertility. Lancet 1975;1:605-607
CrossRef | Web of Science | Medline38
Aune A ,Alraek T ,Huo L ,Barheim A . Kan akupunktur forebygge blærekatarr hos kvinner? Tidsskr Nor Laegeforen 1998;118:1370-1372
Medline39
Heinzl S ,Andor J . Preoperative administration of prostaglandin to avoid dilatation-induced damage in first-trimester pregnancy terminations. Gynecol Obstet Invest 1981;12:29-36
CrossRef | Web of Science | Medline40
Tarrier N ,Yusupoff L ,Kinney C , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ 1998;317:303-307
CrossRef | Web of Science | Medline41
Whittaker CB ,Hoy RM . Withdrawal of perphenazine in chronic schizophrenia. Br J Psychiatry 1963;109:422-427
CrossRef | Web of Science | Medline42
Frank E ,Kupfer DJ ,Perel JM , et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47:1093-1099
Web of Science | Medline43
Klerman GL ,Dimascio A ,Weisman M ,Prusoff B ,Paykel ES . Treatment of depression by drugs and psychotherapy. Am J Psychiatry 1974;131:186-191
Web of Science | Medline44
Rabkin JG ,McGrath PJ ,Quitkin FM ,Tricamo E ,Stewart JW ,Klein DF . Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. Am J Psychiatry 1990;147:1622-1626
Web of Science | Medline45
Roughan PA ,Kunst L . Do pelvic floor exercises really improve orgasmic potential? J Sex Marital Ther 1981;7:223-229
CrossRef | Web of Science | Medline46
Berg I ,Forsythe I ,Holt P ,Watts J . A controlled trial of `Senokot' in faecal soiling treated by behavioral methods. J Child Psychol Psychiatry 1983;24:543-549
CrossRef | Web of Science | Medline47
Blackman S ,Benton AJ ,Cove LM . The effect of imipramine on enuresis. Am J Psychiatry 1964;120:1194-1195
Web of Science | Medline48
Double DB ,Warren GC ,Evans M ,Rowlands RP . Efficacy of maintenance use of anticholinergic agents. Acta Psychiatr Scand 1993;88:381-384
CrossRef | Web of Science | Medline49
Stransky M ,Rubin A ,Lava NS ,Lazaro RP . Treatment of carpal tunnel syndrome with vitamin B6: a double-blind study. South Med J 1989;82:841-842
CrossRef | Web of Science | Medline50
Tan S ,Bruni J . Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia 1986;27:225-233
CrossRef | Web of Science | Medline51
Antivalle M ,Lattuada S ,Salvaggio M ,Paravicini M ,Rindi M ,Libretti A . Placebo effect and adaptation to noninvasive monitoring of BP. J Hum Hypertens 1990;4:633-637
Web of Science | Medline52
Bosley F ,Allen TW . Stress management training for hypertensives: cognitive and physiological effects. J Behav Med 1989;12:77-89
CrossRef | Web of Science | Medline53
Canino E ,Cardona R ,Monsalve P ,Acuna FP ,Lopez B ,Fragachan F . A behavioral treatment program as a therapy in the control of primary hypertension. Acta Cient Venez 1994;45:23-30
Medline54
Frankel BL ,Patel DJ ,Horwitz D ,Friedewald WT ,Gaarder KR . Treatment of hypertension with biofeedback and relaxation techniques. Psychosom Med 1978;40:276-293
Web of Science | Medline55
Rossi A ,Ziacchi V ,Lomanto B . The hypotensive effect of a single daily dose of labetalol: a preliminary study. Int J Clin Pharmacol Ther Toxicol 1982;20:438-445
Medline56
Seer P ,Raeburn JM . Meditation training and essential hypertension: a methodological study. J Behav Med 1980;3:59-71
CrossRef | Medline57
Yates RG ,Lamping DL ,Abram NL ,Wright C . Effects of chiropractic treatment on blood pressure and anxiety: a randomized, controlled trial. J Manipulative Physiol Ther 1988;11:484-488
Web of Science | Medline58
Block J . Effects of rational emotive therapy on overweight adults. Psychother Theory Res Pract 1980;17:277-280
CrossRef | Web of Science59
Hall RG ,Hanson RW ,Borden BL . Permanence of two self-managed treatments of overweight in university and community populations. J Consult Clin Psychol 1974;42:781-786
CrossRef | Web of Science | Medline60
Hanson RW ,Borden BL ,Hall SM ,Hall RG . Use of programmed instruction in teaching self-management skills to overweight adults. Behav Ther 1976;7:366-373
CrossRef | Web of Science61
Murphy JK ,Williamson DA ,Buxton AE ,Moody SC ,Absher N ,Warner M . The long-term effects of spouse involvement upon weight loss and maintenance. Behav Ther 1982;13:681-693
CrossRef | Web of Science62
Senediak C ,Spence SH . Rapid versus gradual scheduling of therapeutic contact in a family based behavioral weight control programme for children. Behav Psychother 1985;13:265-287
CrossRef | Web of Science63
Godfrey S ,Silverman M . Demonstration of a placebo response in asthma by means of exercise testing. J Psychosom Res 1973;17:293-297
CrossRef | Web of Science | Medline64
May O ,Hansen NCG . Comparison of terbutaline, isotonic saline, ambient air and non-treatment in patients with reversible chronic airway obstruction. Eur Respir J 1988;1:527-530
Web of Science | Medline65
Morton AR ,Fazio SM ,Miller D . Efficacy of laser-acupuncture in the prevention of exercise-induced asthma. Ann Allergy 1993;70:295-298
Medline66
Lindholm LH ,Ekbom T ,Dash C ,Isacsson A ,Schersten B . Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study. J Intern Med 1996;240:13-22
CrossRef | Web of Science | Medline67
Tuomilehto J ,Voutilainen E ,Huttunen J ,Vinni S ,Homan K . Effect of guar gum on body weight and serum lipids in hypercholesterolemic females. Acta Med Scand 1980;208:45-48
CrossRef | Web of Science | Medline68
Diamond L ,Dockhorn RJ ,Grossman J , et al. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol 1995;95:1139-1146
CrossRef | Web of Science | Medline69
Hayden FG ,Diamond L ,Wood PB ,Korts DC ,Wecker MT . Effectiveness and safety of intranasal ipratropium bromide in common colds: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;125:89-97
Web of Science | Medline70
Stabholz A ,Shapira J ,Shur D ,Friedman M ,Guberman R ,Sela MN . Local application of sustained-release delivery system of chlorhexidine in Down's syndrome population. Clin Prev Dent 1991;13:9-14
Medline71
Stewart JE ,Jacobs-Schoen M ,Padilla MR ,Maeder LA ,Wolfe GR ,Hartz GW . The effect of a cognitive behavioral intervention on oral hygiene. J Clin Periodontol 1991;18:219-222
CrossRef | Web of Science | Medline72
Sipich JF ,Russell RK ,Tobias LL . A comparison of covert sensitization and “nonspecific“ treatment in the modification of smoking behavior. J Behav Ther Exp Psychiatry 1974;5:201-203
CrossRef | Web of Science73
Spanos NP ,Mondoux TJ ,Burges CA . Comparison of multi-component hypnotic and non-hypnotic treatments for smoking. Contemp Hypn 1995;12:12-1974
Longo DJ ,Clum GA ,Yaeger NJ . Psychosocial treatment for recurrent genital herpes. J Consult Clin Psychol 1988;56:61-66
CrossRef | Web of Science | Medline75
Crosby L ,Palarski VA ,Cottington E ,Cmolik B . Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study. Heart Lung 1994;23:493-499
Web of Science | Medline76
Karunakaran S ,Hammersley MS ,Morris RC ,Turner RC ,Holman RR . The Fasting Hyperglycaemia Study. III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose. Metabolism 1997;46:Suppl 1:56-60
CrossRef | Web of Science | Medline77
Nawrocki JD ,Bell TJ ,Lawrence WT ,Ward JP . A randomized controlled trial of transurethral microwave thermotherapy. Br J Urol 1997;79:389-393
CrossRef | Medline78
GRECHO, U292 INSERM, ARC, GREPA. Evaluation de deux produits homéopathiques sur la reprise du transit après chirurgie digestive: un essai contrôlé multicentrique. Presse Med 1989;18:59-62
Web of Science | Medline79
Nyboe Andersen A ,Damm P ,Tabor A ,Pedersen IM ,Harring M . Prevention of breast pain and milk secretion with bromocriptine after second-trimester abortion. Acta Obstet Gynecol Scand 1990;69:235-238
CrossRef | Web of Science | Medline80
Benedetti F ,Amanzio M ,Maggi G . Potentiation of placebo analgesia by proglumide. Lancet 1995;346:1231-1231
CrossRef | Web of Science | Medline81
Benedetti F ,Amanio M ,Casadio C , et al. Control of postoperative pain by transcutaneous electrical nerve stimulation after thoracic operations. Ann Thorac Surg 1997;63:773-776
CrossRef | Web of Science | Medline82
Chenard JR ,Marchand S ,Charest J ,Jinxue L ,Lavignolle B . Évaluation d'un traitement comportmental de la lombalgie chronique: l'école interactionelle du dos. Sci Comportement 1991;21:225-23983
Classen W ,Feingold E ,Netter P . Influence of sensory suggestibility on treatment outcome in headache patients. Neuropsychobiology 1983;10:44-47
CrossRef | Web of Science | Medline84
Conn IG ,Marshall AH ,Yadav SN ,Daly JC ,Jaffer M . Transcutaneous electrical nerve stimulation following appendicectomy: the placebo effect. Ann R Coll Surg Engl 1986;68:191-192
Web of Science | Medline85
Coyne P ,MacMurren M ,Izzo T ,Kramer T . Transcutaneous electrical nerve stimulator for procedural pain associated with intravenous needlesticks. J Intraven Nurs 1995;18:263-267
Medline86
Forster EL ,Kramer JF ,Lucy SD ,Scudds RA ,Novick RJ . Effects of TENS on pain, medications, and pulmonary function following coronary artery bypass graft surgery. Chest 1994;106:1343-1348
CrossRef | Web of Science | Medline87
Frega A ,Stentella P ,Di Renzi F , et al. Pain evaluation during carbon dioxide laser vaporization for cervical intraepithelial neoplasia: a randomized trial. Clin Exp Obstet Gynecol 1994;21:188-191
Medline88
Goodenough B ,Kampel L ,Champion GD , et al. An investigation of the placebo effect and age-related factors in the report of needle pain from venipuncture in children. Pain 1997;72:383-391
CrossRef | Web of Science | Medline89
Gracely RH ,Dubner R ,Wolskee PJ ,Deeter WR . Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature 1983;306:264-265
CrossRef | Web of Science | Medline90
Hargreaves A ,Lander J . Use of transcutaneous electrical nerve stimulation for postoperative pain. Nurs Res 1989;38:159-161
CrossRef | Web of Science | Medline91
Hashish I ,Harvey W ,Harris M . Anti-inflammatory effects of ultrasound therapy: evidence for a major placebo effect. Br J Rheumatol 1986;25:77-81
CrossRef | Medline92
Hashish I ,Hai HK ,Harvey W ,Feinmann C ,Harris M . Reduction of postoperative pain and swelling by ultrasound treatment: a placebo effect. Pain 1988;33:303-311
CrossRef | Web of Science | Medline93
Helms JM . Acupuncture for the management of primary dysmenorrhea. Obstet Gynecol 1987;69:51-56
Web of Science | Medline94
Hong CZ ,Chen YC ,Pon CH ,Yu J . Immediate effects of various physical medicine modalities on pain threshold of an active myofascial trigger point. Musculoskeletal Pain 1993;1:37-53
CrossRef95
Lander J ,Fowler-Kerry S . TENS for children's procedural pain. Pain 1993;52:209-216
CrossRef | Web of Science | Medline96
Levine JD ,Gordon NC . Influence of the method of drug administration on analgesic response. Nature 1984;312:755-756
CrossRef | Web of Science | Medline97
Moffett JAK ,Richardson PH ,Frost H ,Osborn A . A placebo controlled double blind trial to evaluate the effectiveness of pulsed short wave therapy for osteoarthritic hip and knee pain. Pain 1996;67:121-127
CrossRef | Web of Science | Medline98
Parker JC ,Smarr KL ,Buckelew SP , et al. Effects of stress management on clinical outcomes in rheumatoid arthritis. Arthritis Rheum 1995;38:1807-1818
CrossRef | Web of Science | Medline99
Reading AE . The effects of psychological preparation on pain and recovery after minor gynaecological surgery: a preliminary report. J Clin Psychol 1982;38:504-512
CrossRef | Web of Science | Medline100
Rowbotham MC ,Davies PS ,Verkempinck C ,Galer BS . Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44
CrossRef | Web of Science | Medline101
Sanders GE ,Reinert O ,Tepe R ,Maloney P . Chiropractic adjustive manipulation on subjects with acute low back pain: visual analog pain scores and plasma beta-endorphin levels. J Manipulative Physiol Ther 1990;13:391-395
Web of Science | Medline102
Sprott H ,Mennet P ,Stratz T ,Muller W . Wirksamkeit der Akupunktur bei Patienten mit generalisierter Tendomyopathie (Fibromyalgie). Aktuel Rheumatol 1993;18:132-135
CrossRef | Web of Science103
Tan S ,Poser EG . Acute pain in a clinical setting: effects of cognitive-behavioural skills training. Behav Res Ther 1982;20:535-545
CrossRef | Web of Science | Medline104
Vlaeyen JWS ,Teeken-Gruben NJG ,Goossens MEJB , et al. Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. I. Clinical effects. J Rheumatol 1996;23:1237-1245
Web of Science | Medline105
Wojciechowski FL . Behavioral treatment of tension headache: a contribution to controlled outcome research methodology. Gedrag Tijdschrift Voor Psychol 1984;12:16-30106
Hawkins PJ ,Liossi C ,Ewart BW ,Hatria P ,Kosmidis VH ,Varvutsi M . Hypnotherapy for control of anticipatory nausea and vomiting in children with cancer: preliminary findings. Psychooncology 1995;4:101-106
CrossRef | Web of Science107
O'Brien B ,Relyea MJ ,Taerum T . Efficacy of P6 acupressure in the treatment of nausea and vomiting during pregnancy. Am J Obstet Gynecol 1996;174:708-715
CrossRef | Web of Science | Medline108
Tremeau ML ,Fontanie-Ravier P ,Teurnier F ,Demouzon J . Protocole de maturation cervicale par acupuncture. J Gynecol Obstet Biol Reprod (Paris) 1992;21:375-380
Medline109
Irvin JH ,Domar AD ,Clark C ,Zuttermeister PC ,Friedman R . The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynaecol 1996;17:202-207
CrossRef | Web of Science | Medline110
Ascher LM ,Turner RM . Paradoxical intention and insomnia: an experimental investigation. Behav Res Ther 1979;17:408-411
CrossRef | Web of Science | Medline111
Espie CA ,Lindsay WR ,Brooks DN ,Hood EM ,Turvey T . A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behav Res Ther 1989;27:79-88
CrossRef | Web of Science | Medline112
Lick JR ,Heffler D . Relaxation training and attention placebo in the treatment of severe insomnia. J Consult Clin Psychol 1977;45:153-161
CrossRef | Web of Science | Medline113
Nicassio P ,Bootzin R . A comparison of progressive relaxation and autogenic training as treatments for insomnia. J Abnorm Psychol 1974;83:253-260
CrossRef | Web of Science | Medline114
Turner RM ,Ascher LM . Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. J Consult Clin Psychol 1979;47:500-508
CrossRef | Web of Science | Medline115
Kendall PC ,Williams L ,Pechacek TF ,Graham LE ,Shisslak C ,Herzoff N . Cognitive-behavioral and patient education interventions in cardiac catheterization: the Palo Alto Medical Psychology Project. J Consult Clin Psychol 1979;47:49-58
CrossRef | Web of Science | Medline116
Lorr M ,McNair DM ,Weinstein GJ ,Michaux WW ,Raskin A . Meprobamate and chlorpromazine in psychotherapy: same effects on anxiety and hostility of outpatients. Arch Gen Psychiatry 1961;4:381-389
Web of Science | Medline117
Macaluso AD ,Connelly AM ,Hayes WB , et al. Oral transmucosal fentanyl citrate for premedication in adults. Anesth Analg 1996;82:158-161
CrossRef | Web of Science | Medline118
Markland D ,Hardy L . Anxiety, relaxation and anaesthesia for day-case surgery. Br J Clin Psychol 1993;32:493-504
CrossRef | Web of Science | Medline119
Rybarczyk BD ,Auerbach SM . Reminiscence interviews as stress management interventions for older patients undergoing surgery. Gerontologist 1990;30:522-528
CrossRef | Web of Science | Medline120
Theroux MC ,West DW ,Corddry DH , et al. Efficacy of intranasal midazolam in facilitating suturing of lacerations in preschool children in the emergency department. Pediatrics 1993;9:624-627121
Lick J . Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. J Consult Clin Psychol 1975;43:557-567
CrossRef | Web of Science | Medline122
Rosen GM ,Glasgow RE ,Barrera M . A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. J Consult Clin Psychol 1976;44:208-217
CrossRef | Web of Science | Medline123
Fuchs CZ ,Rehm LP . A self-control behavior therapy program for depression. J Consult Clin Psychol 1977;45:206-215
CrossRef | Web of Science | Medline124
Nandi DN ,Ajmany S ,Ganguli H , et al. A clinical evaluation of depressives found in a rural survey in India. Br J Psychiatry 1976;128:523-527
CrossRef | Web of Science | Medline125
Davidson AM ,Denney DR ,Elliott CH . Suppression and substitution in the treatment of nailbiting. Behav Res Ther 1980;18:1-9
CrossRef | Web of Science | Medline126
Bramston P ,Spence SH . Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behav Res Ther 1985;23:239-246
CrossRef | Web of Science | Medline127
Jacobson NS . Specific and nonspecific factors in the effectiveness of a behavioral approach to the treatment of marital discord. J Consult Clin Psychol 1978;46:442-452
CrossRef | Web of Science | Medline128
Nocella J ,Kaplan RM . Training children to cope with dental treatment. J Pediatr Psychol 1982;7:175-178
CrossRef | Medline129
Weingaertner AH . Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. J Consult Clin Psychol 1971;36:422-429
CrossRef | Web of Science | Medline130
Crapper McLachlan DR ,Dalton AJ ,Kruck TPA , et al. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 1991;337:1304-1308[Erratum, Lancet 1991;337:1618.]
CrossRef | Web of Science | Medline131
Quayhagen MP ,Quayhagen M ,Corbeil RR ,Roth P ,Rodgers JA . A dyadic remediation program for care recipients with dementia. Nurs Res 1995;44:153-159
CrossRef | Web of Science | Medline132
Pelham WE ,Murphy DA ,Vannatta K , et al. Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. J Consult Clin Psychol 1992;60:282-292
CrossRef | Web of Science | Medline133
Ernst E ,Resch KL . Concept of true and perceived placebo effects. BMJ 1995;311:551-553
CrossRef | Web of Science | Medline134
Gotzsche PC . Sensitivity of effect variables in rheumatoid arthritis: a meta-analysis of 130 placebo controlled NSAID trials. J Clin Epidemiol 1990;43:1313-1318[Erratum, J Clin Epidemiol 1991;44:613.]
CrossRef | Web of Science | Medline135
Adams HG ,Benson EA ,Alexander ER ,Ventrer LA ,Remington MA ,Holmes KK . Genital herpetic infection in men and women: clinical course and effect of topical application of adenine arabinoside. J Infect Dis 1976;133:Suppl:A151-A159
CrossRef | Web of Science | Medline136
Banner CN ,Meadows WM . Examination of the effectiveness of various treatment techniques for reducing tension. Br J Clin Psychol 1983;22:183-193
CrossRef | Web of Science | Medline137
Brill NQ ,Koegler RR ,Epstein LJ ,Forgy EW . Controlled study of psychiatric outpatient treatment. Arch Gen Psychiatry 1964;10:581-595
Web of Science | Medline138
Doty DW . Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. J Consult Clin Psychol 1975;43:676-682
CrossRef | Web of Science | Medline139
Gracely RH ,Deeter WR ,Wolskee PJ , et al. The effect of naloxone on multidimensional scales of postsurgical pain in nonsedated patients. Soc Neurosci Abstr 1979;5:609-609140
Grammer LC ,Shaughnessy MA ,Shaughnessy JJ ,Patterson R . Asthma as a variable in a study of immunotherapy for allergic rhinitis. J Allergy Clin Immunol 1984;73:557-560
CrossRef | Web of Science | Medline141
Hallstrom C ,Crouch G ,Robsen M ,Shine P . The treatment of tranquillizer dependence by propranolol. Postgrad Med J 1988;64:Suppl 2:40-44
Web of Science | Medline142
Irjala J ,Kanto J ,Scheinin M . Monoamine metabolite and catecholamine measurements in cerebrospinal fluid in determining the quality of the pre-operative night's sleep. Eur J Anaesthesiol 1993;10:393-396
Web of Science | Medline143
Jakes SC ,Hallam RS ,McKenna L ,Hinchcliffe R . Group cognitive therapy for medical patients: an application to tinnitus. Cognit Ther Res 1992;16:67-82
CrossRef | Web of Science144
Lamazza A ,Tofi A ,Bolognese A ,Fontana B ,De Masi E ,Frontespezi S . Effects of pinaverium bromide in the premedication of endoscopic retrograde cholangio-pancreatography and on motor activity of the sphincter of Oddi. Cur Med Res Opin 1986;10:280-284
CrossRef | Web of Science | Medline145
Levitt M ,Wilson A ,Bowman D , et al. Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10 and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy: ophthalmologic implications. J Clin Pharmacol 1981;21:Suppl 8-9:103S-109S
CrossRef | Web of Science | Medline146
Mussell MJ ,Hartley JP . Trachea-noise biofeedback in asthma: a comparison of the effect of trachea-noise biofeedback, a bronchodilator, and no treatment on the rate of recovery from exercise- and eucapnic hyperventilation-induced asthma. Biofeedback Self Regul 1988;13:219-234
CrossRef | Medline147
Pearl D ,Vander Kamp H ,Olsen AL ,Greenberg PD ,Armitage SG . The effects of reserpine on schizophrenic patients. Am J Psychiatry 1956;112:936-936
Web of Science | Medline148
Rupert PA ,Holmes DS . Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology 1978;15:582-590
CrossRef | Web of Science | Medline149
Sibilio JP ,Andrew G ,Dart D ,Moore KB ,Stehman VA . Treatment of chronic schizophrenia with promazine hydrochloride. AMA Arch Neurol Psychiatry 1957;78:419-424
Web of Science | Medline150
Sommerness MD ,Lucero RJ ,Hamlon JS ,Erickson JL ,Matthews R . A controlled study of reserpine on chronically disturbed patients. AMA Arch Neurol Psychiatry 1955;74:316-319
Web of Science | Medline
- Citing Articles (385)
Citing Articles
1
Deusvenir de Souza Carvalho, Liselotte Menke Barea, Pedro André Kowacs, Yara Dadalti Fragoso. (2012) Efficacy and tolerability of combined dipyrone, isometheptene and caffeine in the treatment of mild-to-moderate primary headache episodes. Expert Review of Neurotherapeutics 12:2, 159-167
CrossRef2
Patricia Wheaton, Jane L. Mathias, Robert Vink. (2011) Impact of Pharmacological Treatments on Cognitive and Behavioral Outcome in the Postacute Stages of Adult Traumatic Brain Injury. Journal of Clinical Psychopharmacology 31:6, 745-757
CrossRef3
Melvin L. Morse, Lance W. Beem. (2011) Benefits of Reiki Therapy for a Severely Neutropenic Patient with Associated Influences on a True Random Number Generator. The Journal of Alternative and Complementary Medicine111201124637009
CrossRef4
Ian M. Handley, Stephanie L. Fowler, Heather M. Rasinski, Suzanne G. Helfer, Andrew L. Geers. (2011) Beliefs About Expectations Moderate the Influence of Expectations on Pain Perception. International Journal of Behavioral Medicine
CrossRef5
Emanuel Severus, Ilya Lipkovich, Florian Seemüller, Michael Obermeier, Heinz Grunze, Britta Bernhard, Sandra Dittmann, Michael Riedel, Hans-Jürgen Möller. (2011) The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practice. World Journal of Biological Psychiatry1-10
CrossRef6
Asbjørn Hróbjartsson, Ted J. Kaptchuk, Franklin G. Miller. (2011) Placebo effect studies are susceptible to response bias and to other types of biases. Journal of Clinical Epidemiology 64:11, 1223-1229
CrossRef7
A Hróbjartsson, I Boutron. (2011) Blinding in Randomized Clinical Trials: Imposed Impartiality. Clinical Pharmacology & Therapeutics 90:5, 732-736
CrossRef8
J.-P. Lefaucheur, N. André-Obadia, E. Poulet, H. Devanne, E. Haffen, A. Londero, B. Cretin, A.-M. Leroi, A. Radtchenko, G. Saba, H. Thai-Van, C.-F. Littré, L. Vercueil, D. Bouhassira, S.-S. Ayache, W.-H. Farhat, H.-G. Zouari, V. Mylius, M. Nicolier, L. Garcia-Larrea. (2011) Recommandations françaises sur l’utilisation de la stimulation magnétique transcrânienne répétitive (rTMS) : règles de sécurité et indications thérapeutiques. Neurophysiologie Clinique/Clinical Neurophysiology
CrossRef9
Annette van Maanen, Anne Marie Meijer, Marcel G. Smits, Frans J. Oort. (2011) Termination of short term melatonin treatment in children with delayed Dim Light Melatonin Onset: Effects on sleep, health, behavior problems, and parenting stress. Sleep Medicine 12:9, 875-879
CrossRef10
Phyllis Zelkowitz, Nancy Feeley, Ian Shrier, Robyn Stremler, Ruta Westreich, David Dunkley, Russell Steele, Zeev Rosberger, Francine Lefebvre, Apostolos Papageorgiou. (2011) The Cues and Care Randomized Controlled Trial of a Neonatal Intensive Care Unit Intervention: Effects on Maternal Psychological Distress and Mother-Infant Interaction. Journal of Developmental & Behavioral Pediatrics 32:8, 591-599
CrossRef11
Per E. Wändell, Axel C. Carlsson, Catharina Gåfvels, Katarina Andersson, Lena Törnkvist. (2011) Measuring possible effect on health-related quality of life by tactile massage or relaxation in patients with type 2 diabetes. Complementary Therapies in Medicine
CrossRef12
Tuomas K. Pernu. (2011) Minding matter: how not to argue for the causal efficacy of the mental. Reviews in the Neurosciences 22:5, 483-507
CrossRef13
Atsushi Hashizume, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Noriaki Suga, Fumiaki Tanaka, Gen Sobue. (2011) Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy. Journal of Neurology
CrossRef14
Andrew Turner. (2011) ‘Placebos’ and the logic of placebo comparison. Biology & Philosophy
CrossRef15
Joram Ronel, Julinda Mehilli, Karl-Heinz Ladwig, Hannah Blättler, Nina Oversohl, Robert A. Byrne, Axel Bauer, Simon Schneider, Klaus Linde, Peter Henningsen, Claas Lahmann, Michael Noll-Hussong, Karin Meissner. (2011) Effects of verbal suggestion on coronary arteries: Results of a randomized controlled experimental investigation during coronary angiography. American Heart Journal 162:3, 507-511
CrossRef16
Paul Enck, Bjoern Horing, Katja Weimer, Sibylle Klosterhalfen. (2011) Placebo responses and placebo effects in functional bowel disorders. European Journal of Gastroenterology & Hepatology1
CrossRef17
Jason P. Rose, Andrew L. Geers, Heather M. Rasinski, Stephanie L. Fowler. (2011) Choice and placebo expectation effects in the context of pain analgesia. Journal of Behavioral Medicine
CrossRef18
Donald A. Redelmeier, Victoria M. Dickinson. (2011) Determining Whether a Patient is Feeling Better: Pitfalls from the Science of Human Perception. Journal of General Internal Medicine 26:8, 900-906
CrossRef19
Herand Abcarian. (2011) Routine Antibiotics for Anorectal Abscess: The Answer Is Still No. Diseases of the Colon & Rectum 54:8, 917-918
CrossRef20
Sanjay Rajagopalan, Georgeta Mihai. (2011) Perspectives on Optimizing Trial Design and Endpoints in Peripheral Arterial Disease: A Case for Imaging-Based Surrogates as Endpoints of Functional Efficacy. Cardiology Clinics 29:3, 419-431
CrossRef21
Wechsler, Michael E., Kelley, John M., Boyd, Ingrid O.E., Dutile, Stefanie, Marigowda, Gautham, Kirsch, Irving, Israel, Elliot, Kaptchuk, Ted J.. (2011) Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma. New England Journal of Medicine 365:2, 119-126
Full Text22
Altaf Mangera, Christopher R. Chapple, Zoe S. Kopp, Melanie Plested. (2011) The placebo effect in overactive bladder syndrome. Nature Reviews Urology 8:9, 495-503
CrossRef23
Chin-wern Chan, Philip W.H. Peng. (2011) Suprascapular Nerve Block. Regional Anesthesia and Pain Medicine 36:4, 358-373
CrossRef24
Simon R. Brice, Brett S. Jarosz, Rick A. Ames, James Baglin, Cliff Da Costa. (2011) The effect of close proximity holographic wristbands on human balance and limits of stability: A randomised, placebo-controlled trial. Journal of Bodywork and Movement Therapies 15:3, 298-303
CrossRef25
Jean-Marie Berthelot. (2011) Response to the comment by Rémy Boussageon (The placebo effect: Still under a cloud of confusion) on the article by Berthelot et al. (The placebo effect in rheumatology). Joint Bone Spine 78:4, 433-434
CrossRef26
Rémy Boussageon. (2011) The placebo effect: Still under a cloud of confusion. Comments on the update by J.-M. Berthelot. Joint Bone Spine 78:4, 433
CrossRef27
L. Colloca, F. G. Miller. (2011) Harnessing the placebo effect: the need for translational research. Philosophical Transactions of the Royal Society B: Biological Sciences 366:1572, 1922-1930
CrossRef28
K. Linde, M. Fassler, K. Meissner. (2011) Placebo interventions, placebo effects and clinical practice. Philosophical Transactions of the Royal Society B: Biological Sciences 366:1572, 1905-1912
CrossRef29
M. S. Mora, Y. Nestoriuc, W. Rief. (2011) Lessons learned from placebo groups in antidepressant trials. Philosophical Transactions of the Royal Society B: Biological Sciences 366:1572, 1879-1888
CrossRef30
K. Meissner. (2011) The placebo effect and the autonomic nervous system: evidence for an intimate relationship. Philosophical Transactions of the Royal Society B: Biological Sciences 366:1572, 1808-1817
CrossRef31
Jack Coulehan. (2011) Deep hope: A song without words. Theoretical Medicine and Bioethics 32:3, 143-160
CrossRef32
Nathalie André-Obadia, Michel Magnin, Luis Garcia-Larrea. (2011) On the importance of placebo timing in rTMS studies for pain relief. PAIN 152:6, 1233-1237
CrossRef33
Atsushi Ogawa, Shiro Hinotsu, Hisashi Urushihara, Koji Kawakami. (2011) Night-to-night variability of sleep latency significantly predicts the magnitude of subsequent change in sleep latency during placebo administration. Sleep Medicine 12:6, 565-571
CrossRef34
Eric Manheimer. (2011) Selecting a control for in vitro fertilization and acupuncture randomized controlled trials (RCTs): how sham controls may unnecessarily complicate the RCT evidence base. Fertility and Sterility 95:8, 2456-2461
CrossRef35
Andrew L. Geers, Justin A. Wellman, Stephanie L. Fowler, Heather M. Rasinski, Suzanne G. Helfer. (2011) Placebo expectations and the detection of somatic information. Journal of Behavioral Medicine 34:3, 208-217
CrossRef36
2011. References. , 193-223.
CrossRef37
D. Corydon Hammond. (2011) Placebos and Neurofeedback: A Case for Facilitating and Maximizing Placebo Response in Neurofeedback Treatments. Journal of Neurotherapy 15:2, 94-114
CrossRef38
Majid Reza Farrokhi, Ehsanali Alibai, Zohre Maghami. (2011) Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery: Spine1-9
CrossRef39
John E. O'Toole, Vincent C. Traynelis. (2011) Editorial. Journal of Neurosurgery: Spine1-5
CrossRef40
Paul Arnstein, Kathleen Broglio, Elsa Wuhrman, Mary Beth Kean. (2011) Use of Placebos in Pain Management. Pain Management Nursing
CrossRef41
Jean-Marie Berthelot. (2011) The placebo effect in rheumatology: New data. Joint Bone Spine 78:2, 161-165
CrossRef42
Qing Zhao, Zhi-hong Liu, Qin Luo, Zhi-hui Zhao, Hong-liang Zhang, Yong Wang. (2011) Effects of continuous positive airway pressure on blood pressure and daytime sleepiness in obstructive sleep apnea patients with coronary heart diseases under optimal medications. Sleep and Breathing
CrossRef43
Richard L. Kradin. (2011) Placebo Response: A Consideration of its Role in Therapeutics. Current Psychiatry Reports 13:1, 37-42
CrossRef44
Bruce J Kinon, Alison J Potts, Susan B Watson. (2011) Placebo response in clinical trials with schizophrenia patients. Current Opinion in Psychiatry1
CrossRef45
S. McGuirk, C. Fahy, D. Costi, A. M. Cyna. (2011) Use of invasive placebos in research on local anaesthetic interventions. Anaesthesia 66:2, 84-91
CrossRef46
Henning Zeidler. (2011) Paracetamol and the Placebo Effect in Osteoarthritis Trials: A Missing Link?. Pain Research and Treatment 2011, 1-6
CrossRef47
Andrew J Hahne, Jon J Ford, Luke D Surkitt, Matthew C Richards, Alexander YP Chan, Sarah L Thompson, Rana S Hinman, Nicholas F Taylor. (2011) Specific treatment of problems of the spine (STOPS): design of a randomised controlled trial comparing specific physiotherapy versus advice for people with subacute low back disorders. BMC Musculoskeletal Disorders 12:1, 104
CrossRef48
Karen Wager-Smith, Athina Markou. (2011) Depression: A repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?. Neuroscience & Biobehavioral Reviews 35:3, 742-764
CrossRef49
Ulrike Bingel, Luana Colloca, Lene Vase. (2011) Mechanisms and Clinical Implications of the Placebo Effect: Is There a Potential for the Elderly? A Mini-Review. Gerontology 57:4, 354-363
CrossRef50
Maurizio Marogna, Igino Spadolini, Alessandro Massolo, Giorgio Walter Canonica, Giovanni Passalacqua. (2010) Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study. Journal of Allergy and Clinical Immunology 126:5, 969-975
CrossRef51
Paul Enck, Sibylle Klosterhalfen, Stephan Zipfel. (2010) Acupuncture, psyche and the placebo response. Autonomic Neuroscience 157:1-2, 68-73
CrossRef52
George Philip, Arlene S. Swern, Steven S. Smugar, David S. Pearlman. (2010) Baseline Predictors of Placebo Response in Exercise-Induced Bronchoconstriction (EIB): Pooled Regression Analysis >From Three Studies of Montelukast in EIB. Journal of Asthma 47:8, 935-941
CrossRef53
Yukitoshi Aoyagi, Hyuntae Park, Sungjin Park, Kazuhiro Yoshiuchi, Hiroe Kikuchi, Hiroshi Kawakami, Yoshikazu Morita, Aiko Ono, Roy J. Shephard. (2010) Interactive effects of milk basic protein supplements and habitual physical activity on bone health in older women: A 1-year randomized controlled trial. International Dairy Journal 20:10, 724-730
CrossRef54
MH Pittler, JL Bosson. (2010) Spa therapy for knee osteoarthritis - a fair test?. Focus on Alternative and Complementary Therapies 15:3, 257-258
CrossRef55
Jozien M. Bensing, William Verheul. (2010) The silent healer: The role of communication in placebo effects. Patient Education and Counseling 80:3, 293-299
CrossRef56
Thomas J Povsic, Christopher M O’Connor. (2010) Cell therapy for heart failure: the need for a new therapeutic strategy. Expert Review of Cardiovascular Therapy 8:8, 1107-1126
CrossRef57
Henda Foreid, Carla Bentes, José Pimentel. (2010) The Use of Placebo as a Provocative Test in the Diagnosis of Psychogenic Non Epileptic Seizures. Neuroethics 3:2, 95-98
CrossRef58
Roy La Touche, Greg Goddard, José Luis De-la-Hoz, Kelun Wang, Alba Paris-Alemany, Santiago Angulo-Díaz-Parreño, Juan Mesa, Mar Hernández. (2010) Acupuncture in the Treatment of Pain in Temporomandibular Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials. The Clinical Journal of Pain 26:6, 541-550
CrossRef59
Jens Foell. (2010) Is electro-acupuncture a safe and cost-effective treatment for Achilles tendonopathy in a primary care setting?. International Musculoskeletal Medicine 32:2, 51-54
CrossRef60
K.L. Bennell, M.A. Hunt, T.V. Wrigley, D.J. Hunter, F.J. McManus, P.W. Hodges, L. Li, R.S. Hinman. (2010) Hip strengthening reduces symptoms but not knee load in people with medial knee osteoarthritis and varus malalignment: a randomised controlled trial. Osteoarthritis and Cartilage 18:5, 621-628
CrossRef61
U. Bingel. (2010) Mechanismen der endogenen Schmerzmodulation am Beispiel der Placeboanalgesie. Der Schmerz 24:2, 122-129
CrossRef62
A R Stark, J E Tyson, P L Hibberd. (2010) Variation among institutional review boards in evaluating the design of a multicenter randomized trial. Journal of Perinatology 30:3, 163-169
CrossRef63
e. kokkotou, l. a. conboy, d.c. ziogas, m. t. quilty, j. m. kelley, r. b. davis, a. j. lembo, t. j. kaptchuk. (2010) Serum correlates of the placebo effect in irritable bowel syndrome. Neurogastroenterology & Motility 22:3, 285-e81
CrossRef64
Damien G Finniss, Ted J Kaptchuk, Franklin Miller, Fabrizio Benedetti. (2010) Biological, clinical, and ethical advances of placebo effects. The Lancet 375:9715, 686-695
CrossRef65
Maxine de la Cruz, David Hui, Henrique A. Parsons, Eduardo Bruera. (2010) Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer 116:3, 766-774
CrossRef66
E Paul Cherniack. (2010) Would the elderly be better off if they were given more placebos?. Geriatrics & Gerontology International
CrossRef67
Felipe Fregni, Marta Imamura, Hsin Fen Chien, Henry L. Lew, Paulo Boggio, Ted J. Kaptchuk, Marcelo Riberto, Wu Tu Hsing, Linamara Rizzo Battistella, Andrea Furlan. (2010) Challenges and Recommendations for Placebo Controls in Randomized Trials in Physical and Rehabilitation Medicine. American Journal of Physical Medicine & Rehabilitation 89:2, 160-172
CrossRef68
Philip D Shenefelt. (2010) Update on psychodermatological disorders. Expert Review of Dermatology 5:1, 95-107
CrossRef69
Rebecca Y. Steer, Emory University, Lorie A. Ritschel. 2010. Placebo. .
CrossRef70
Eric Manheimer, Ke Cheng, Klaus Linde, Lixing Lao, Junghee Yoo, Susan Wieland, Daniëlle AWM van der Windt, Brian M Berman, Lex M Bouter, Eric Manheimer. 2010. Acupuncture for peripheral joint osteoarthritis. .
CrossRef71
Asbjørn Hróbjartsson, Peter C Gøtzsche, Asbjørn Hróbjartsson. 2010. Placebo interventions for all clinical conditions. .
CrossRef72
A.B. Guekht, A.D. Korczyn, I.B. Bondareva, E.I. Gusev. (2010) Placebo responses in randomized trials of antiepileptic drugs. Epilepsy & Behavior 17:1, 64-69
CrossRef73
W. C. GALLAHAN, D. CASE, R. S. BLOOMFELD. (2010) An analysis of the placebo effect in Crohnâs disease over time. Alimentary Pharmacology & Therapeutics 31:1, 102-107
CrossRef74
Hsueh-Chieh Lu, Jen-Chuen Hsieh, Ching-Liang Lu, David M. Niddam, Yu-Te Wu, Tzu-Chen Yeh, Chou-Ming Cheng, Full-Young Chang, Shou-Dong Lee. (2010) Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: A 3T-fMRI study. PAIN 148:1, 75-83
CrossRef75
Kavita R. Shah, Susan Dorr Goold. (2009) The Primacy of Autonomy, Honesty, and Disclosure—Council on Ethical and Judicial Affairs' Placebo Opinions. The American Journal of Bioethics 9:12, 15-17
CrossRef76
Bennett Foddy. (2009) A Duty to Deceive: Placebos in Clinical Practice. The American Journal of Bioethics 9:12, 4-12
CrossRef77
Franklin G. Miller, Luana Colloca. (2009) The Legitimacy of Placebo Treatments in Clinical Practice: Evidence and Ethics. The American Journal of Bioethics 9:12, 39-47
CrossRef78
Daniela Lucini, Mara Malacarne, Nadia Solaro, Silvano Busin, Massimo Pagani. (2009) Complementary medicine for the management of chronic stress: superiority of active versus passive techniques. Journal of Hypertension 27:12, 2421-2428
CrossRef79
Artur Carvalho de Araujo, Fernando Gomes da Silva, Fernando Salvi, Monique Carvalho Awad, EloÃsio Alexsandro da Silva, Ronaldo Damião. (2009) The Management of Erectile Dysfunction with Placebo Only: Does it Work?. Journal of Sexual Medicine 6:12, 3440-3448
CrossRef80
Winfried Rief, Yvonne Nestoriuc, Sarah Weiss, Eva Welzel, Arthur J. Barsky, Stefan G. Hofmann. (2009) Meta-analysis of the placebo response in antidepressant trials. Journal of Affective Disorders 118:1-3, 1-8
CrossRef81
Mei-Chi Hsu, Hsiu-Wen Chen, Yueh-Juen Hwu, Chin-Mu Chanc, Chi-Feng Liu. (2009) Effects of thermal therapy on uremic pruritus and biochemical parameters in patients having haemodialysis. Journal of Advanced Nursing 65:11, 2397-2408
CrossRef82
Lauren Y. Atlas, Tor D. Wager, Katharine P. Dahl, Edward E. Smith. 2009. Placebo Effects. .
CrossRef83
Yun-Hai Qiu, Xin-Yin Wu, Hao Xu, David Sackett. (2009) Neuroimaging study of placebo analgesia in humans. Neuroscience Bulletin 25:5, 277-282
CrossRef84
Yun Hyung Koog, Byung-Il Min. (2009) Does Random Participant Assignment Cause Fewer Benefits in Research Participants? Systematic Review of Partially Randomized Acupuncture Trials. The Journal of Alternative and Complementary Medicine 15:10, 1107-1113
CrossRef85
M. Doherty, P. Dieppe. (2009) The “placebo” response in osteoarthritis and its implications for clinical practice. Osteoarthritis and Cartilage 17:10, 1255-1262
CrossRef86
Chung-Yee Cecilia Ho, Gisela Sole, Joanne Munn. (2009) The effectiveness of manual therapy in the management of musculoskeletal disorders of the shoulder: A systematic review. Manual Therapy 14:5, 463-474
CrossRef87
Stephen Senn. (2009) Placebo Misconceptions. The American Journal of Bioethics 9:9, 53-54
CrossRef88
Lene Vase, Gitte Laue Petersen, Joseph L. Riley, Donald D. Price. (2009) Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. PAIN 145:1-2, 36-44
CrossRef89
Ted J. Kaptchuk, Jessica Shaw, Catherine E. Kerr, Lisa A. Conboy, John M. Kelley, Thomas J. Csordas, Anthony J. Lembo, Eric E. Jacobson. (2009) “Maybe I Made Up the Whole Thing”: Placebos and Patients’ Experiences in a Randomized Controlled Trial. Culture, Medicine, and Psychiatry 33:3, 382-411
CrossRef90
Kallmes, David F., Comstock, Bryan A., Heagerty, Patrick J., Turner, Judith A., Wilson, David J., Diamond, Terry H., Edwards, Richard, Gray, Leigh A., Stout, Lydia, Owen, Sara, Hollingworth, William, Ghdoke, Basavaraj, Annesley-Williams, Deborah J., Ralston, Stuart H., Jarvik, Jeffrey G., . (2009) A Randomized Trial of Vertebroplasty for Osteoporotic Spinal Fractures. New England Journal of Medicine 361:6, 569-579
Full Text91
P. Enck, S. Zipfel, S. Klosterhalfen. (2009) Der Placeboeffekt in der Medizin. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 52:6, 635-642
CrossRef92
Leonard S. Milling. (2009) Response expectancies: a psychological mechanism of suggested and placebo analgesia. Contemporary Hypnosis 26:2, 93-110
CrossRef93
Kenneth A. Holroyd, Jenifer S. Labus, Bruce Carlson. (2009) Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: The role of disorder severity and psychiatric comorbidity. PAIN 143:3, 213-222
CrossRef94
Karin Meissner. (2009) Effects of placebo interventions on gastric motility and general autonomic activity. Journal of Psychosomatic Research 66:5, 391-398
CrossRef95
Karen L. Overall, Arthur E. Dunham. (2009) Homeopathy and the curse of the scientific method. The Veterinary Journal 180:2, 141-148
CrossRef96
Christopher Eccleston, Amanda C de C Williams, Stephen Morley, Christopher Eccleston. 2009. Psychological therapies for the management of chronic pain (excluding headache) in adults. .
CrossRef97
John M. Kelley, Patrick R. Boulos, Peter A.D. Rubin, Ted J. Kaptchuk. (2009) Mirror, mirror on the wall: placebo effects that exist only in the eye of the beholder. Journal of Evaluation in Clinical Practice 15:2, 292-298
CrossRef98
John R. Hughes. (2009) Ethical concerns about non-active conditions in smoking cessation trials and methods to decrease such concerns. Drug and Alcohol Dependence 100:3, 187-193
CrossRef99
Michael E. Oakes. (2009) Students’ Beliefs About Placebo Responders: Implications for Fundamentals of Psychology Courses. Current Psychology 28:1, 12-20
CrossRef100
Jon-Kar Zubieta, Christian S. Stohler. (2009) Neurobiological Mechanisms of Placebo Responses. Annals of the New York Academy of Sciences 1156:1, 198-210
CrossRef101
Jennifer Jo Thompson, Cheryl Ritenbaugh, Mark Nichter. (2009) Reconsidering the Placebo Response from a Broad Anthropological Perspective. Culture, Medicine, and Psychiatry 33:1, 112-152
CrossRef102
J. A. J. Smits, S. G. Hofmann. (2009) A meta-analytic review of the effects of psychotherapy control conditions for anxiety disorders. Psychological Medicine 39:02, 229
CrossRef103
Sae Yong Lee, Patrick McKeon, Jay Hertel. (2009) Does the use of orthoses improve self-reported pain and function measures in patients with plantar fasciitis? A meta-analysis. Physical Therapy in Sport 10:1, 12-18
CrossRef104
Suzanne M. Bertisch, Anna R. T. Legedza, Russell S. Phillips, Roger B. Davis, William B. Stason, Rose H. Goldman, Ted J. Kaptchuk. (2009) The impact of psychological factors on placebo responses in a randomized controlled trial comparing sham device to dummy pill. Journal of Evaluation in Clinical Practice 15:1, 14-19
CrossRef105
Hideto MIWA. (2009) Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 40:4, 145-150
CrossRef106
Margaret E. Kemeny. (2009) Psychobiological responses to social threat: Evolution of a psychological model in psychoneuroimmunology. Brain, Behavior, and Immunity 23:1, 1-9
CrossRef107
James D. Lewis, Shaokun Chuai, Lisa Nessel, Gary R. Lichtenstein, Faten N. Aberra, Jonas H. Ellenberg. (2008) Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis. Inflammatory Bowel Diseases 14:12, 1660-1666
CrossRef108
Peter la Cour. (2008) Rheumatic Disease and Complementary-Alternative Treatments. JCR: Journal of Clinical Rheumatology 14:6, 332-337
CrossRef109
Helmut Raab, Karl H. Lindner, Volker Wenzel. (2008) Preventing cardiac arrest during hemorrhagic shock with vasopressin. Critical Care Medicine 36:Suppl, S474-S480
CrossRef110
Anne Holbrook, Charles H. Goldsmith, Mova Leung. 2008. Placebos. .
CrossRef111
M. PASCUA, C. SU, J. D. LEWIS, C. BRENSINGER, G. R. LICHTENSTEIN. (2008) Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics 28:5, 545-556
CrossRef112
RM Douglas, H Hemilä, E Chalker, B Treacy. (2008) Cochrane review: Vitamin C for preventing and treating the common cold. Evidence-Based Child Health: A Cochrane Review Journal 3:3, 672-720
CrossRef113
Michael JL Sullivan, Mary E Lynch, A John Clark, Tsipora Mankovsky, Jana Sawynok. (2008) Catastrophizing and treatment outcome: differential impact on response to placebo and active treatment outcome. Contemporary Hypnosis 25:3-4, 129-140
CrossRef114
Yanlin Wang-Fischer, Lee Koetzner. 2008. Study Design in Animal Models of Stroke. , 305-313.
CrossRef115
Carmen Paradis. (2008) Bias in Surgical Research. Annals of Surgery 248:2, 180-188
CrossRef116
James Malone-Lee. (2008) A defence of rigorous method in clinical science. Neurourology and Urodynamics 27:6, 462-465
CrossRef117
E. M. Tsapakis, F. Soldani, L. Tondo, R. J. Baldessarini. (2008) Efficacy of antidepressants in juvenile depression: meta-analysis. The British Journal of Psychiatry 193:1, 10-17
CrossRef118
H. HEMILÄ. (2008) Assessment of the importance of double-blinding should be based on systematic reviews: a rebuttal. Journal of Thrombosis and Haemostasis 6:7, 1247-1248
CrossRef119
Winfried Rief, Stefan G. Hofmann, Yvonne Nestoriuc. (2008) The Power of Expectation – Understanding the Placebo and Nocebo Phenomenon. Social and Personality Psychology Compass 2:4, 1624-1637
CrossRef120
Ted J. Kaptchuk, John M. Kelley, Aaron Deykin, Peter M. Wayne, Louis C. Lasagna, Ingrid O. Epstein, Irving Kirsch, Michael E. Wechsler. (2008) Do “placebo responders” exist?. Contemporary Clinical Trials 29:4, 587-595
CrossRef121
Carolina Kimie Moriyama, Bruna Oneda, Fernanda Rocchi Bernardo, Crivaldo Gomes Cardoso, Claudia L. M. Forjaz, Sandra B. Abrahao, Décio Mion, Ângela M. Fonseca, Tais Tinucci. (2008) A randomized, placebo-controlled trial of the effects of physical exercises and estrogen therapy on health-related quality of life in postmenopausal women. Menopause 15:4, 613-618
CrossRef122
Paul Enck, Fabrizio Benedetti, Manfred Schedlowski. (2008) New Insights into the Placebo and Nocebo Responses. Neuron 59:2, 195-206
CrossRef123
Vanda Faria, Mats Fredrikson, Tomas Furmark. (2008) Imaging the placebo response: A neurofunctional review. European Neuropsychopharmacology 18:7, 473-485
CrossRef124
B. S. Oken. (2008) Placebo effects: clinical aspects and neurobiology. Brain 131:11, 2812-2823
CrossRef125
Hannes G Lienhart, Karl H Lindner, Volker Wenzel. (2008) Developing alternative strategies for the treatment of traumatic haemorrhagic shock. Current Opinion in Critical Care 14:3, 247-253
CrossRef126
F Schwarz, D Christie. (2008) Use of ‘sham’ radiotherapy in randomized clinical trials. Journal of Medical Imaging and Radiation Oncology 52:3, 269-277
CrossRef127
Antonella Pollo, Fabrizio Benedetti. (2008) Placebo Response: Relevance to the Rheumatic Diseases. Rheumatic Disease Clinics of North America 34:2, 331-349
CrossRef128
J. Oeltjenbruns, M. Schäfer. (2008) Klinische Bedeutung des Placeboeffektes. Der Anaesthesist 57:5, 447-463
CrossRef129
Satoru Shikata, Takeo Nakayama, Hisakazu Yamagishi. (2008) Quality of surgical randomized controlled trials for acute cholecystitis: assessment based on CONSORT and additional check items. Journal of Hepato-Biliary-Pancreatic Surgery 15:3, 297-303
CrossRef130
Harri Hemilä, Teija Koivula, Harri Hemilä. 2008. Vitamin C for preventing and treating tetanus. .
CrossRef131
Christopher G. Goetz, Joanne Wuu, Michael P. McDermott, Charles H. Adler, Stanley Fahn, Curt R. Freed, Robert A. Hauser, Warren C. Olanow, Ira Shoulson, P.K. Tandon, , Sue Leurgans. (2008) Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions. Movement Disorders 23:5, 690-699
CrossRef132
MARJEAN TAYLOR KULP, ERIC BORSTING, G LYNN MITCHELL, MITCHELL SCHEIMAN, SUSAN COTTER, JEFFREY COOPER, MICHAEL ROUSE, RICHARD LONDON, JANICE WENSVEEN. (2008) Feasibility of Using Placebo Vision Therapy in a Multicenter Clinical Trial. Optometry and Vision Science 85:4, 255-261
CrossRef133
David C. Nieman. (2008) RESPONSE. Medicine & Science in Sports & Exercise 40:4, 776
CrossRef134
Philip D Shenefelt. (2008) Therapeutic management of psychodermatological disorders. Expert Opinion on Pharmacotherapy 9:6, 973-985
CrossRef135
Romain Forestier, Alain Françon. (2008) Crénobalnéothérapie de l’arthrose des membres, revue systématique et analyse méthodologique. Revue du Rhumatisme 75:3, 214-224
CrossRef136
Romain Forestier, Alain Françon. (2008) Crenobalneotherapy for limb osteoarthritis: Systematic literature review and methodological analysis. Joint Bone Spine 75:2, 138-148
CrossRef137
Steven J. Kamper, Luciana A.C. Machado, Robert D. Herbert, Christopher G. Maher, James H. McAuley. (2008) Trial methodology and patient characteristics did not influence the size of placebo effects on pain. Journal of Clinical Epidemiology 61:3, 256-260
CrossRef138
Reinhild Klein, Sandra Buck, Karen Claßen, Matthias Rostock, Roman Huber. (2008) Enhanced in vitro activation of immunocompetent cells in healthy individuals being subcutaneously ‘vaccinated’ with placebo (physiological saline). Clinical Immunology 126:3, 322-331
CrossRef139
Thomas Ostermann, Gisela Blaser, Mathias Bertram, Andreas Michalsen, Peter F. Matthiessen, Karin Kraft. (2008) Effects of Rhythmic Embrocation Therapy With Solum Oil in Chronic Pain Patients. The Clinical Journal of Pain 24:3, 237-243
CrossRef140
Sibylle Klosterhalfen, Paul Enck. (2008) Neurophysiology and psychobiology of the placebo response. Current Opinion in Psychiatry 21:2, 189-195
CrossRef141
Benno Brinkhaus, Daniel Pach, Rainer Lüdtke, Stefan N. Willich. (2008) Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials. Contemporary Clinical Trials 29:2, 149-156
CrossRef142
Luana Colloca, Fabrizio Benedetti, Carlo Adolfo Porro. (2008) Experimental designs and brain mapping approaches for studying the placebo analgesic effect. European Journal of Applied Physiology 102:4, 371-380
CrossRef143
Fabrizio Benedetti. (2008) Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments. Annual Review of Pharmacology and Toxicology 48:1, 33-60
CrossRef144
W. Zhang, R.W. Moskowitz, G. Nuki, S. Abramson, R.D. Altman, N. Arden, S. Bierma-Zeinstra, K.D. Brandt, P. Croft, M. Doherty, M. Dougados, M. Hochberg, D.J. Hunter, K. Kwoh, L.S. Lohmander, P. Tugwell. (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 16:2, 137-162
CrossRef145
Heather O Dickinson, Fiona R Beyer, Gary A Ford, Donald Nicolson, Fiona Campbell, Julia V Cook, James Mason, Heather O Dickinson. 2008. Relaxation therapies for the management of primary hypertension in adults. .
CrossRef146
Graeme Hawthorne, Robert Goldney, Anne W. Taylor. (2008) Depression prevalence: is it really increasing?. Australian and New Zealand Journal of Psychiatry 42:7, 606-616
CrossRef147
Michael R. Graham, Julien S. Baker, Peter Evans, Andrew Kicman, David Cowan, David Hullin, Non Thomas, Bruce Davies. (2008) Physical Effects of Short-Term Recombinant Human Growth Hormone Administration in Abstinent Steroid Dependency. Hormone Research 69:6, 343-354
CrossRef148
Anup Malani, Daniel Houser. 2008. Expectations mediate objective physiological placebo effects. , 311-327.
CrossRef149
Donald D. Price, Damien G. Finniss, Fabrizio Benedetti. (2008) A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought. Annual Review of Psychology 59:1, 565-590
CrossRef150
Rachel Sherman, John Hickner. (2008) Academic Physicians Use Placebos in Clinical Practice and Believe in the Mind–Body Connection. Journal of General Internal Medicine 23:1, 7-10
CrossRef151
C. Mel Wilcox. (2008) Exploring the use of the sham design for interventional trials: implications for endoscopic research. Gastrointestinal Endoscopy 67:1, 123-127
CrossRef152
Bruce A. Buehler. (2007) Complementary and alternative medicine (CAM) in genetics. American Journal of Medical Genetics Part A 143A:24, 2889-2892
CrossRef153
Kenneth F. Schulz. 2007. Double-Dummy. .
CrossRef154
Reidar Aarskog, Mark I. Johnson, Jan Hendrik Demmink, Anne Lofthus, Vegard Iversen, Rodrigo Lopes-Martins, Jon Joensen, Jan M. Bjordal. (2007) Is mechanical pain threshold after transcutaneous electrical nerve stimulation (TENS) increased locally and unilaterally? A randomized placebo-controlled trial in healthy subjects. Physiotherapy Research International 12:4, 251-263
CrossRef155
Enno Freye, Joseph Victor Levy, Dagmar Braun. (2007) Effervescent Morphine Results in Faster Relief of Breakthrough Pain in Patients Compared to Immediate Release Morphine Sulfate Tablet. Pain Practice 7:4, 324-331
CrossRef156
Jason G. Craggs, Donald D. Price, G. Nicholas Verne, William M. Perlstein, Michael M. Robinson. (2007) Functional brain interactions that serve cognitive–affective processing during pain and placebo analgesia. NeuroImage 38:4, 720-729
CrossRef157
David M. Marsh, Teresa J. Hanlon. (2007) Seeing What We Want to See: Confirmation Bias in Animal Behavior Research. Ethology 113:11, 1089-1098
CrossRef158
R. Jungbecker, M. Zenz. (2007) BGH-Urteil zum Racz-Katheter. Der Schmerz 21:6, 553-556
CrossRef159
Roman Huber, Amelie v. Ditfurth, Frank Amann, Corina Güthlin, Matthias Rostock, Rainer Trittler, Klaus Kümmerer, Irmgard Merfort. (2007) Tormentil for Active Ulcerative Colitis. Journal of Clinical Gastroenterology 41:9, 834-838
CrossRef160
John L. Sievenpiper, Adish Ezatagha, Anamaria Dascalu, Vladimir Vuksan. (2007) When a placebo is not a ?placebo?: a placebo effect on postprandial glycaemia. British Journal of Clinical Pharmacology 64:4, 546-549
CrossRef161
Laura McRee, Alice Pasvogel, Alton V. Hallum, Steve E. Behr, Francisco A.R. Garcia, Robert G. Loeb. (2007) Effects of Preoperative Massage on Intra- and Postoperative Outcomes. Journal of Gynecologic Surgery 23:3, 97-104
CrossRef162
Celal B. Erdogmus, Karl-Ludwig Resch, Ronald Sabitzer, Horst M??ller, Martin Nuhr, Andreas Sch??ggl, Martin Posch, Wolf Osterode, Karl Ungersb??ck, Gerold R. Ebenbichler. (2007) Physiotherapy-Based Rehabilitation Following Disc Herniation Operation. Spine 32:19, 2041-2049
CrossRef163
Jan Van Zundert. (2007) Clinical Research in Interventional Pain Management Techniques: The Clinician's Point of View. Pain Practice 7:3, 221-229
CrossRef164
Patricia A. Roche. (2007) Pain and placebo analgesia: two sides of the same coin. Physical Therapy Reviews 12:3, 189-198
CrossRef165
E. Randy Eichner. (2007) Sports medicine pearls and pitfalls: Pearls on the power of placebo. Current Sports Medicine Reports 6:4, 208-209
CrossRef166
s. d. dorn, t. j. kaptchuk, j. b. park, l. t. nguyen, k. canenguez, b. h. nam, k. b. woods, l. a. conboy, w. B. stason, a. j. lembo. (2007) A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome. Neurogastroenterology & Motility 19:8, 630-637
CrossRef167
Harri Hemilä, Elizabeth Chalker, Bob Douglas, Harri Hemilä. 2007. Vitamin C for preventing and treating the common cold. .
CrossRef168
H Hemilä, TT Koivula, Harri Hemilä. 2007. Vitamin C for preventing and treating tetanus. .
CrossRef169
H-C Diener, G Bussone, JC Van Oene, M Lahaye, S Schwalen, PJ Goadsby, . (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27:7, 814-823
CrossRef170
David J. Scott, Christian S. Stohler, Christine M. Egnatuk, Heng Wang, Robert A. Koeppe, Jon-Kar Zubieta. (2007) Individual Differences in Reward Responding Explain Placebo-Induced Expectations and Effects. Neuron 55:2, 325-336
CrossRef171
Margaret E. Kemeny, Lanny J. Rosenwasser, Reynold A. Panettieri, Robert M. Rose, Steve M. Berg-Smith, Joel N. Kline. (2007) Placebo response in asthma: A robust and objective phenomenon. Journal of Allergy and Clinical Immunology 119:6, 1375-1381
CrossRef172
Haim Shmuely, Jacob Yahav, Zmira Samra, Gabriel Chodick, Rivka Koren, Yaron Niv, Itzhak Ofek. (2007) Effect of cranberry juice on eradication ofHelicobacter pyloriin patients treated with antibiotics and a proton pump inhibitor. Molecular Nutrition & Food Research 51:6, 746-751
CrossRef173
Stephen Polgar, Joanna Ng. (2007) A critical analysis of evidence for using sham surgery in Parkinson's disease: implications for public health. Australian and New Zealand Journal of Public Health 31:3, 270-274
CrossRef174
Andrew L. Geers, Kristin Kosbab, Suzanne G. Helfer, Paul E. Weiland, Justin A. Wellman. (2007) Further evidence for individual differences in placebo responding: An interactionist perspective. Journal of Psychosomatic Research 62:5, 563-570
CrossRef175
Klaus Linde, Claudia M. Witt, Andrea Streng, Wolfgang Weidenhammer, Stefan Wagenpfeil, Benno Brinkhaus, Stefan N. Willich, Dieter Melchart. (2007) The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. PAIN 128:3, 264-271
CrossRef176
Beverly Thorn. (2007) Commentaries on the placebo concept in psychotherapy. Journal of Clinical Psychology 63:4, 371-372
CrossRef177
Bruce E. Wampold, Zac E. Imel, Takuya Minami. (2007) The placebo effect: “Relatively large” and “robust” enough to survive another assault. Journal of Clinical Psychology 63:4, 401-403
CrossRef178
Asbjørn Hróbjartsson, Peter C. Gøtzsche. (2007) Wampold et al.'s reiterate spin in the conclusion of a re-analysis of placebo versus no-treatment trials despite similar results as in original review. Journal of Clinical Psychology 63:4, 405-408
CrossRef179
Asbjørn Hróbjartsson, Peter C. Gøtzsche. (2007) Powerful spin in the conclusion of wampold et al.'s re-analysis of placebo versus no-treatment trials despite similar results as in original review. Journal of Clinical Psychology 63:4, 373-377
CrossRef180
Bruce E. Wampold, Zac E. Imel, Takuya Minami. (2007) The story of placebo effects in medicine: Evidence in context. Journal of Clinical Psychology 63:4, 379-390
CrossRef181
R. Forestier, A. Françon, F. Saint-Arromand, C. Bertolino, A. Guillemot, B. Graber-Duvernay, M. Slikh, B. Duplan. (2007) Y a-t-il un effet des soins thermaux et des champs électromagnétiques pulsés sur la cervicalgie chronique? Essai clinique randomisé Première partie: étude clinique. Annales de Réadaptation et de Médecine Physique 50:3, 140-147
CrossRef182
John Hunsley, Robin Westmacott. (2007) Interpreting the magnitude of the placebo effect: Mountain or molehill?. Journal of Clinical Psychology 63:4, 391-399
CrossRef183
Stephen Senn. (2007) Statistics in the pharmaceutical industry (3rd edn). C. Ralph Buncher and Jia-Yeong Tsay (eds), Chapman & Hall/CRC, New York, 2006. No. of pages: xxiii+473. Price: $119.95. ISBN: 0-8247-5469-7. Statistics in Medicine 26:7, 1651-1652
CrossRef184
Simon Wessely. (2007) A Defence of the Randomized Controlled Trial in Mental Health. BioSocieties 2:1, 115-127
CrossRef185
John C. Licciardone. (2007) Responding to the challenge of clinically relevant osteopathic research: Efficacy and beyond. International Journal of Osteopathic Medicine 10:1, 3-7
CrossRef186
LYNDA BÉLANGER, ANNIE VALLIÈRES, HANS IVERS, VINCENT MOREAU, GILLES LAVIGNE, CHARLES M. MORIN. (2007) Meta-analysis of sleep changes in control groups of insomnia treatment trials. Journal of Sleep Research 16:1, 77-84
CrossRef187
E. C.-H. Lim, R. C. S. Seet. (2007) Attitudes of medical students to placebo therapy. Internal Medicine Journal 37:3, 156-160
CrossRef188
Edvin B. Koshi, Christine Ann Short. (2007) Placebo Theory and Its Implications for Research and Clinical Practice: A Review of the Recent Literature. Pain Practice 7:1, 4-20
CrossRef189
An-Shine Chao, Angel Chao, Tzu-Hao Wang, Yu-Cheng Chang, Hsiu-Huei Peng, Shuenn-Dyh Chang, Anne Chao, Chee-Jen Chang, Chyong-Huey Lai, Alice M.K. Wong. (2007) Pain relief by applying transcutaneous electrical nerve stimulation (TENS) on acupuncture points during the first stage of labor: A randomized double-blind placebo-controlled trial. PAIN 127:3, 214-220
CrossRef190
Aaron K. Vallance. (2007) A systematic review comparing the functional neuroanatomy of patients with depression who respond to placebo to those who recover spontaneously: Is there a biological basis for the placebo effect in depression?. Journal of Affective Disorders 98:1-2, 177-185
CrossRef191
Howard L. Fields, Donald D. Price. 2007. Analgesia mediante placebo. , 369-376.
CrossRef192
Frank Zimmermann-Viehoff, Karin Meissner. (2007) Homeopathy and Placebo – Synonym, Similar or Different?. Forschende Komplementärmedizin / Research in Complementary Medicine 14:4, 247-248
CrossRef193
Jan Van Zundert, Jacob Patijn, Alfons Kessels, Inge Lamé, Hans van Suijlekom, Maarten van Kleef. (2007) Pulsed radiofrequency adjacent to the cervical dorsal root ganglion in chronic cervical radicular pain: A double blind sham controlled randomized clinical trial. Pain 127:1-2, 173-182
CrossRef194
Donald D. Price, Jason Craggs, G. Nicholas Verne, William M. Perlstein, Michael E. Robinson. (2007) Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 127:1-2, 63-72
CrossRef195
Heinz-Dieter Basler, Helmut Bertalanffy, Sabine Quint, Axel Wilke, Udo Wolf. (2007) TTM-based counselling in physiotherapy does not contribute to an increase of adherence to activity recommendations in older adults with chronic low back pain – A randomised controlled trial. European Journal of Pain 11:1, 31-37
CrossRef196
Daniel E. Moerman. (2006) The Meaning Response: Thinking about Placebos. Pain Practice 6:4, 233-236
CrossRef197
Rainer Schneider, Mauritz Grüner, Alexandra Heiland, Martina Keller, Zuzana Kujanová, Martin Peper, Maximilian Riegl, Stefan Schmidt, Petra Volz, Harald Walach. (2006) Effects of expectation and caffeine on arousal, well-being, and reaction time. International Journal of Behavioral Medicine 13:4, 330-339
CrossRef198
Donald D. Price, Roger B. Fillingim, Michael E. Robinson. (2006) Placebo analgesia: Friend or foe?. Current Rheumatology Reports 8:6, 418-424
CrossRef199
Bradley Chipps, Roland Buhl, Kai-Michael Beeh, Howard Fox, Karen Thomas, Colin Reisner. (2006) Improvement in quality of life with omalizumab in patients with severe allergic asthma. Current Medical Research and Opinion 22:11, 2201-2208
CrossRef200
Luana Colloca, Fabrizio Benedetti. (2006) How prior experience shapes placebo analgesia. Pain 124:1-2, 126-133
CrossRef201
Paul S. Heckerling. (2006) Placebo surgery research: A blinding imperative. Journal of Clinical Epidemiology 59:9, 876-880
CrossRef202
Gustavo Pacheco-López, Harald Engler, Maj-Britt Niemi, Manfred Schedlowski. (2006) Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology. Brain, Behavior, and Immunity 20:5, 430-446
CrossRef203
Jules H. Schagen van Leeuwen, Ramiro Castro, Michael Busse, Bart L.H. Bemelmans. (2006) The Placebo Effect in the Pharmacologic Treatment of Patients with Lower Urinary Tract Symptoms. European Urology 50:3, 440-453
CrossRef204
K. Linde. (2006) Der spezifische Placeboeffekt. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 49:8, 729-735
CrossRef205
Peter Jüni, Stephan Reichenbach, Paul Dieppe. (2006) Osteoarthritis: rational approach to treating the individual. Best Practice & Research Clinical Rheumatology 20:4, 721-740
CrossRef206
Robert L. Tiel, David G. Kline. (2006) Piriformis Syndrome. Journal of Neurosurgery: Spine 5:1, 102-104
CrossRef207
D D'Amico, A Solari, S Usai, P Santoro, P Bernardoni, F Frediani, R De Marco, N Massetto, G Bussone, . (2006) Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 26:6, 691-696
CrossRef208
H Drutz. (2006) Duloxetine in women awaiting surgery. BJOG: An International Journal of Obstetrics & Gynaecology 113, 17-21
CrossRef209
Michael A. Posternak, David A. Solomon, Andrew C. Leon, Timothy I. Mueller, M Tracie Shea, Jean Endicott, Martin B. Keller. (2006) The Naturalistic Course of Unipolar Major Depression in the Absence of Somatic Therapy. The Journal of Nervous and Mental Disease 194:5, 324-329
CrossRef210
Carmen WH Chan, David R Thompson. (2006) The use of placebo in clinical nursing research. Journal of Clinical Nursing 15:5, 521-524
CrossRef211
Tor D. Wager, Dagfinn Matre, Kenneth L. Casey. (2006) Placebo effects in laser-evoked pain potentials. Brain, Behavior, and Immunity 20:3, 219-230
CrossRef212
Rémy Boussageon, François Gueyffier, Alain Moreau, Vincent Boussageon. (2006) La difficile mesure de l'effet placebo. Thérapie 61:3, 185-190
CrossRef213
Harri Hemilä. (2006) Analysis of clinical data with breached blindness by Shein-Chung Chow and Jun Shao,Statistics in Medicine 2004;23:1185–1193. Statistics in Medicine 25:8, 1434-1437
CrossRef214
Chinyu Su. (2006) Outcomes of placebo therapy in inflammatory bowel disease. Inflammatory Bowel Diseases 12:4, 328-333
CrossRef215
Asbjørn Hróbjartsson, Peter C. Gøtzsche. (2006) Unsubstantiated claims of large effects of placebo on pain: serious errors in meta-analysis of placebo analgesia mechanism studies. Journal of Clinical Epidemiology 59:4, 336-338
CrossRef216
Franklin G. Miller, Donald L. Rosenstein. (2006) Response to Commentary. Journal of Clinical Epidemiology 59:4, 339
CrossRef217
Franklin G. Miller, Donald L. Rosenstein. (2006) The nature and power of the placebo effect. Journal of Clinical Epidemiology 59:4, 331-335
CrossRef218
Asbjørn Hróbjartsson, Peter C. Gøtzsche. (2006) Follow-up Commentary. Journal of Clinical Epidemiology 59:4, 340-341
CrossRef219
Stephen Birch. (2006) A Review and Analysis of Placebo Treatments, Placebo Effects, and Placebo Controls in Trials of Medical Procedures When Sham Is Not Inert. The Journal of Alternative and Complementary Medicine 12:3, 303-310
CrossRef220
Ana Macedo, Magí Farré, Josep-E. Baños. (2006) A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials. European Journal of Clinical Pharmacology 62:3, 161-172
CrossRef221
Jacek Spławiński, Jerzy Kuźniar, Krzysztof Filipiak, Waldemar Zieliński. (2006) Evaluation of drug toxicity in clinical trials. Science and Engineering Ethics 12:1, 139-145
CrossRef222
M. Eikermann, T. H.C. Kruger, B. Schiffer, M. Beiderlinden, M. Forsting, M. Schedlowski. (2006) Importance of non-pharmacological mechanism of analgesia with spinal puncture. Acta Anaesthesiologica Scandinavica 50:3, 389-389
CrossRef223
Mark A. Young, Jill L. Cook, Kate E. Webster. (2006) The effect of topical wheatgrass cream on chronic plantar fasciitis: A randomized, double-blind, placebo-controlled trial. Complementary Therapies in Medicine 14:1, 3-9
CrossRef224
Jon-Kar Zubieta, Wai-Ying Yau, David J. Scott, Christian S. Stohler. (2006) Belief or Need? Accounting for individual variations in the neurochemistry of the placebo effect. Brain, Behavior, and Immunity 20:1, 15-26
CrossRef225
R. Ben-Youssef, P.W. Baron, E. Franco, M.H. Walter, T. Lewis, O. Ojogho. (2006) Intrapyloric Injection of Botulinum Toxin A for the Treatment of Persistent Gastroparesis Following Successful Pancreas Transplantation. American Journal of Transplantation 6:1, 214-218
CrossRef226
Felipe Fregni, Paulo S. Boggio, Felix Bermpohl, Fernanda Maia, Sergio P. Rigonatti, Egberto R. Barbosa, Alvaro Pascual-Leone. (2006) Immediate Placebo Effect in Parkinson’s Disease – Is the Subjective Relief Accompanied by Objective Improvement?. European Neurology 56:4, 222-229
CrossRef227
Baba Shiv, Antoine Bechara, Irwin Levin, Joseph W. Alba, James R. Bettman, Laurette Dube, Alice Isen, Barbara Mellers, Ale Smidts, Susan J. Grant, A. Peter Mcgraw. (2005) Decision Neuroscience. Marketing Letters 16:3-4, 375-386
CrossRef228
E. C-H. Lim, E. P. V. Wilder-Smith, B. K. C. Ong, R. C. S. Seet. (2005) Is there a place for placebos in clinical practice?. Internal Medicine Journal 35:12, 734-735
CrossRef229
H. Helmchen. (2005) Ethische Implikationen plazebokontrollierter Prüfungen von Psychopharmaka. Der Nervenarzt 76:11, 1319-1329
CrossRef230
David Borsook, Lino Becerra. (2005) Placebo: From Pain and Analgesia to Preferences and Products. Journal of Marketing Research 42:4, 394-398
CrossRef231
Martin B. Leon, Ran Kornowski, William E. Downey, Giora Weisz, Donald S. Baim, Robert O. Bonow, Robert C. Hendel, David J. Cohen, Ernest Gervino, Roger Laham, Nicholas J. Lembo, Jeffrey W. Moses, Richard E. Kuntz. (2005) A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease. Journal of the American College of Cardiology 46:10, 1812-1819
CrossRef232
J.-J. Aulas. (2005) Placebo et effet placebo. Annales Pharmaceutiques Françaises 63:6, 401-415
CrossRef233
P. J. DEVEREAUX, M. BHANDARI, V. M. MONTORI, B. J. MANNS, W. A. GHALI, G. H. GUYATT. (2005) Double blind, you are the weakest link - goodbye!. Equine Veterinary Journal 37:6, 557-558
CrossRef234
H Hemilä, P Louhiala, Harri Hemilä. 2005. Vitamin C for preventing and treating pneumonia. .
CrossRef235
Patrick Onghena. 2005. Placebo Effect. .
CrossRef236
Fabiana Fratello, Giuseppe Curcio, Michele Ferrara, Cristina Marzano, Alessandro Couyoumdjian, Giovanna Petrillo, Mario Bertini, Luigi Gennaro. (2005) Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures. Psychopharmacology 181:4, 761-770
CrossRef237
Helmut Kiene, Gunver S. Kienle, Tido von Schön-Angerer. (2005) Failure to Exclude False Negative Bias: A Fundamental Flaw in the Trial of Shang et al.. The Journal of Alternative and Complementary Medicine 11:5, 783-783
CrossRef238
Stephen Polgar, Joanna Ng. (2005) Ethics, methodology and the use of placebo controls in surgical trials. Brain Research Bulletin 67:4, 290-297
CrossRef239
David Peters. (2005) Shang et al. Carelessness, Collusion, or Conspiracy?. The Journal of Alternative and Complementary Medicine 11:5, 779-780
CrossRef240
Michael Frass, E. Schuster, Ilse Muchitsch, Jeff Duncan, Walter Gei, Gloria Kozel, Christa Kastinger-Mayr, Anton E. Felleitner, Christian Reiter, Christian Endler, Menachem Oberbaum. (2005) Bias in the Trial and Reporting of Trials of Homeopathy: A Fundamental Breakdown in Peer Review and Standards?. The Journal of Alternative and Complementary Medicine 11:5, 780-782
CrossRef241
George T. Lewith, Harald Walach, Wayne B. Jonas. (2005) Horton Deplores Breach; As Do We His. The Journal of Alternative and Complementary Medicine 11:5, 779-779
CrossRef242
David Reilly. (2005) Sir: Is That Bias?. The Journal of Alternative and Complementary Medicine 11:5, 785-785
CrossRef243
Trevor Thompson, Marjorie Weiss. (2005) Understanding Placebo Effects in Homeopathic Clinical Trials. The Journal of Alternative and Complementary Medicine 11:5, 784-784
CrossRef244
Erik W. Baars, Anja De Bruin. (2005) The Effect of Gencydo ® Injections on Hayfever Symptoms: A Therapeutic Causality Report. The Journal of Alternative and Complementary Medicine 11:5, 863-869
CrossRef245
Philip D. Shenefelt. (2005) Complementary Psychocutaneous Therapies in Dermatology. Dermatologic Clinics 23:4, 723-734
CrossRef246
Colin Cheyne. (2005) Exploiting Placebo Effects for Therapeutic Benefit. Health Care Analysis 13:3, 177-188
CrossRef247
H. H. Harri Hemila. (2005) Echinacea, Vitamin C, the Common Cold, and Blinding. Clinical Infectious Diseases 41:5, 762-763
CrossRef248
(2005) Homoeopathy for sepsis?. Focus on Alternative and Complementary Therapies 10:3, 196-197
CrossRef249
R. B. Fillingim, D. D. Price. (2005) What Is Controlled for in Placebo-Controlled Trials?. Mayo Clinic Proceedings 80:9, 1119-1121
CrossRef250
Anita H. Clayton, Sara G. West, Elizabeth McGarvey, Catherine Leslie, Adrienne Keller. (2005) Biochemical Evidence of the Placebo Effect During the Treatment of Menstrual Migraines. Journal of Clinical Psychopharmacology 25:4, 400-401
CrossRef251
Anne Holbrook, Charles H. Goldsmith, Mova Leung. 2005. Placebos. .
CrossRef252
James D. Herbert, Brandon A. Gaudiano. (2005) Moving from empirically supported treatment lists to practice guidelines in psychotherapy: The role of the placebo concept. Journal of Clinical Psychology 61:7, 893-908
CrossRef253
James D. Herbert, Brandon A. Gaudiano. (2005) Introduction to the special issue on the placebo concept in psychotherapy. Journal of Clinical Psychology 61:7, 787-790
CrossRef254
Luana Colloca, Fabrizio Benedetti. (2005) Science and society: Placebos and painkillers: is mind as real as matter?. Nature Reviews Neuroscience 6:7, 545-552
CrossRef255
Bruce E. Wampold, Takuya Minami, Sandra Callen Tierney, Thomas W. Baskin, Kuldhir S. Bhati. (2005) The placebo is powerful: Estimating placebo effects in medicine and psychotherapy from randomized clinical trials. Journal of Clinical Psychology 61:7, 835-854
CrossRef256
John H.K. Vogel, Steven F. Bolling, Rebecca B. Costello, Erminia M. Guarneri, Mitchell W. Krucoff, John C. Longhurst, Brian Olshansky, Kenneth R. Pelletier, Cynthia M. Tracy, Robert A. Vogel, Robert A. Vogel, Jonathan Abrams, Jeffrey L. Anderson, Eric R. Bates, Bruce R. Brodie, Cindy L. Grines, Peter G. Danias, Gabriel Gregoratos, Mark A. Hlatky, Judith S. Hochman, Sanjiv Kaul, Robert C. Lichtenberg, Jonathan R. Lindner, Robert A. O’Rourke, Gerald M. Pohost, Richard S. Schofield, Samuel J. Shubrooks, Cynthia M. Tracy, William L. Winters. (2005) Integrating Complementary Medicine Into Cardiovascular Medicine. Journal of the American College of Cardiology 46:1, 184-221
CrossRef257
Roy A. E. Bakay. (2005) Neural transplantation. Journal of Neurosurgery 103:1, 6-8
CrossRef258
Bradly P. Jacobs, Stephen Bent, Jeffrey A. Tice, Terri Blackwell, Steven R. Cummings. (2005) An Internet-Based Randomized, Placebo-Controlled Trial of Kava and Valerian for Anxiety and Insomnia. Medicine 84:4, 197-207
CrossRef259
T. D. Borkovec, Nicholas J. Sibrava. (2005) Problems with the use of placebo conditions in psychotherapy research, suggested alternatives, and some strategies for the pursuit of the placebo phenomenon. Journal of Clinical Psychology 61:7, 805-818
CrossRef260
Paul Knipschild, Arnoud Arntz. (2005) Pain patients in a randomized trial did not show a significant effect of a positive consultation. Journal of Clinical Epidemiology 58:7, 708-713
CrossRef261
Irving Kirsch. (2005) Placebo psychotherapy: Synonym or oxymoron?. Journal of Clinical Psychology 61:7, 791-803
CrossRef262
s. m. patel, w. b. stason, a. legedza, s. m. ock, t. j. kaptchuk, l. conboy, k. canenguez, j. k. park, e. kelly, e. jacobson, c. e. kerr, a. j. lembo. (2005) The placebo effect in irritable bowel syndrome trials: a meta-analysis1. Neurogastroenterology and Motility 17:3, 332-340
CrossRef263
JONAS NILSSON. (2005) A Bootstrap Theory of Rationality. Theoria 71:2, 182-199
CrossRef264
R. Forestier, A. Françon, B. Graber-Duvernay. (2005) Les paramètres de validité d'un essai thérapeutique et leur influence sur l'élaboration d'une médecine fondée sur les preuves : revue de la littérature. Annales de Réadaptation et de Médecine Physique 48:5, 250-258
CrossRef265
A Kirkley, R G Marx, S Griffin, W R Dunn. (2005) Clinical Trials in Orthopedic Surgery. Sports Medicine and Arthroscopy Review 13:2, 61-68
CrossRef266
p. enck, s. klosterhalfen. (2005) The placebo response in functional bowel disorders: perspectives and putative mechanisms.. Neurogastroenterology and Motility 17:3, 325-331
CrossRef267
Sarah J. L. Edward, Andrew J. Stevens, David A. Braunholtz, Richard J. Lilford, Teresa Swift. (2005) The Ethics of Placebo-controlled Trials: A Comparison of Inert and Active Placebo Controls. World Journal of Surgery 29:5, 610-614
CrossRef268
E Paulsen, L Korsholm, F Brandrup. (2005) A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris. Journal of the European Academy of Dermatology and Venereology 19:3, 326-331
CrossRef269
Shihong Zhang, Ming Liu, Kjell Asplund, Lin Li, Ming Liu. 2005. Acupuncture for acute stroke. .
CrossRef270
K. Meissner. (2005) Preferring patient-reported to observer-reported outcomes substantially influences the results of the updated systematic review on placebos by Hróbjartsson and Gøtzsche. Journal of Internal Medicine 257:4, 394-394
CrossRef271
M.G. Spigt, P.G. Knipschild, C.P. van Schayck, J.A. Knottnerus. (2005) The validity and ethics of giving placebo in a randomized nonpharmacologic trial was evaluated. Journal of Clinical Epidemiology 58:4, 350-356
CrossRef272
Adrian Sandler. (2005) Placebo effects in developmental disabilities: Implications for research and practice. Mental Retardation and Developmental Disabilities Research Reviews 11:2, 164-170
CrossRef273
Graeme Hawthorne, Richard Osborne. (2005) Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. Australian and New Zealand Journal of Public Health 29:2, 136-142
CrossRef274
DAVID RESNIK, DARRYL ZELDIN, RICHARD SHARP. (2005) Research on Environmental Health Interventions: Ethical Problems and Solutions. Accountability in Research: Policies and Quality Assurance 12:2, 69-101
CrossRef275
Leonard S. Milling, Irving Kirsch, George J. Allen, Erin L. Reutenauer. (2005) The effects of hypnotic and nonhypnotic imaginative suggestion on pain. Annals of Behavioral Medicine 29:2, 116-127
CrossRef276
Fabio Parazzini, Enrico Colli, Liliane Chatenoud, Matteo Malvezzi, Lorenza Olivieri, Francesco Montorsi, Carlo La Vecchia. (2005) Clinical trials in urology: how many patients are required to achieve statistically significant results?. BJU International 95:5, 717-722
CrossRef277
Theodore Pincus, Ingrid Amara, Gary G. Koch. (2005) Continuous indices of core data set measures in rheumatoid arthritis clinical trials: Lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria. Arthritis & Rheumatism 52:4, 1031-1036
CrossRef278
C. Guy-Coichard, F. Boureau. (2005) Comprendre l’effet placebo pour mieux traiter la douleur. La Revue de Médecine Interne 26:3, 226-232
CrossRef279
Roger Robert, Jean-Jacques Labat, Maurice Bensignor, Pascal Glemain, Cédric Deschamps, Sylvie Raoul, Olivier Hamel. (2005) Decompression and Transposition of the Pudendal Nerve in Pudendal Neuralgia: A Randomized Controlled Trial and Long-Term Evaluation. European Urology 47:3, 403-408
CrossRef280
Ted J. Kaptchuk, Franklin G. Miller. (2005) Viewpoint:. Academic Medicine 80:3, 286-290
CrossRef281
Veronica Morton, David J. Torgerson. (2005) Regression to the mean: treatment effect without the intervention. Journal of Evaluation in Clinical Practice 11:1, 59-65
CrossRef282
Alla Katsnelson. (2005) Researchers probe the real effect of placebos. Nature Medicine 11:2, 105-105
CrossRef283
Andrew L. Geers, Paul E. Weiland, Kristin Kosbab, Sarah J. Landry, Suzanne G. Helfer. (2005) Goal Activation, Expectations, and the Placebo Effect.. Journal of Personality and Social Psychology 89:2, 143-159
CrossRef284
Michael Ossege, Thomas Sycha, Martin Aigner, Leopold Schmetterer, Hans-Georg Eichler, Markus M??ller, Franz K??nig, Peter Bauer. (2005) Effect of Information on Reported Adverse Events in a Placebo-Controlled Trial. Drug Safety 28:1, 81-87
CrossRef285
Jim Young, Peter Tschudi, Pierre Périat, Christa Hugenschmidt, Antje Welge-Lüssen, Heiner C. Bucher. (2005) Patients’ Expectations about the Benefit of Antibiotic Treatment: Lessons from a Randomised Controlled Trial. Forschende Komplementärmedizin und Klassische Naturheilkunde / Research in Complementary and Classical Natural Medicine 12:6, 347-349
CrossRef286
France Haour. (2005) Mechanisms of the Placebo Effect and of Conditioning. Neuroimmunomodulation 12:4, 195-200
CrossRef287
Bernard Mazi??res. (2005) Topical Ketoprofen Patch. Drugs in R & D 6:6, 337-344
CrossRef288
Nancy King Reame. (2005) The emerging science of hot flash relief: legitimizing the "obecalp" effect. Menopause 12:1, 4-7
CrossRef289
Diana Wyndham. (2004) Versemaking and lovemaking?W. B. Yeats' ?strange second puberty?: Norman Haire and the Steinach rejuvenation operation. Journal of the History of the Behavioral Sciences 39:1, 25-50
CrossRef290
Bradley C. Johnston, Edward Mills. (2004) n -of-1 Randomized Controlled Trials: An Opportunity for Complementary and Alternative Medicine Evaluation. The Journal of Alternative and Complementary Medicine 10:6, 979-984
CrossRef291
Nicholas Tarrier, Til Wykes. (2004) Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?. Behaviour Research and Therapy 42:12, 1377-1401
CrossRef292
Richard Kradin. (2004) The placebo response complex. Journal of Analytical Psychology 49:5, 617-634
CrossRef293
B.A. O'REILLY, P.L. DWYER, G. HAWTHORNE, S. CLEAVER, E. THOMAS, A. ROSAMILIA, M. FYNES. (2004) TRANSDERMAL POSTERIOR TIBIAL NERVE LASER THERAPY IS NOT EFFECTIVE IN WOMEN WITH INTERSTITIAL CYSTITIS. The Journal of Urology 172:5, 1880-1883
CrossRef294
RM Douglas, H Hemilä, E Chalker, RRD D'Souza, B Treacy, Harri Hemilä. 2004. Vitamin C for preventing and treating the common cold. .
CrossRef295
Reingard B.K. Rohrbock, Johann Hammer, Harald Vogelsang, Nicholas J. Talley, Heinz F. Hammer. (2004) Acupuncture has a Placebo Effect on Rectal Perception but not on Distensibility and Spatial Summation: A Study in Health and IBS. The American Journal of Gastroenterology 99:10, 1990-1997
CrossRef296
Harald Walach, Wayne B. Jonas. (2004) Placebo Research: The Evidence Base for Harnessing Self-Healing Capacities. The Journal of Alternative and Complementary Medicine 10:supplement 1, S-103-S-112
CrossRef297
P. L. Hibberd, A. Patel, . (2004) Challenges in the Design of Antibiotic Equivalency Studies: The Multicenter Equivalency Study of Oral Amoxicillin versus Injectable Penicillin in Children Aged 3-59 Months with Severe Pneumonia. Clinical Infectious Diseases 39:4, 526-531
CrossRef298
A. Hrobjartsson, P. C. Gotzsche. (2004) Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. Journal of Internal Medicine 256:2, 91-100
CrossRef299
Michelle M. Haby, Rob Carter, Cathrine Mihalopoulos, Anne Magnus, Kristy Sanderson, Gavin Andrews, Theo Vos. (2004) Assessing Cost-Effectiveness - Mental Health: introduction to the study and methods. Australian and New Zealand Journal of Psychiatry 38:8, 569-578
CrossRef300
Ilker Yalcin, Richard C Bump. (2004) The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence. American Journal of Obstetrics and Gynecology 191:1, 194-197
CrossRef301
A Jon Stoessl, Raúl de la Fuente-Fernández. (2004) Willing oneself better on placebo—effective in its own right. The Lancet 364:9430, 227-228
CrossRef302
E.A.M. Gale. (2004) The Hawthorne studies--a fable for our times?. QJM 97:7, 439-449
CrossRef303
Edward Gracely. (2004) The Role of Quasi-Experimental Designs in Pain Research. Pain Medicine 5:2, 146-147
CrossRef304
Matthew D Lieberman, Johanna M Jarcho, Steve Berman, Bruce D Naliboff, Brandall Y Suyenobu, Mark Mandelkern, Emeran A Mayer. (2004) The neural correlates of placebo effects: a disruption account. NeuroImage 22:1, 447-455
CrossRef305
Chinyu Su, Gary R. Lichtenstein, Karen Krok, Colleen M. Brensinger, James D. Lewis. (2004) A meta-analysis of the placebo rates of remission and response in clinical trials of active crohn’s disease. Gastroenterology 126:5, 1257-1269
CrossRef306
David T Yu, John Chae, Maria E Walker, Andrew Kirsteins, Elie P Elovic, Steven R Flanagan, Richard L Harvey, Richard D Zorowitz, Frederick S Frost, Julie H Grill, Michael Feldstein, Zi-Ping Fang. (2004) Intramuscular neuromuscular electric stimulation for poststroke shoulder pain: A multicenter randomized clinical trial. Archives of Physical Medicine and Rehabilitation 85:5, 695-704
CrossRef307
R Barker Bausell, Wen-Lin Lee, Karen L Soeken, Yu-Fang Li, Brian M Berman. (2004) Larger effect sizes were associated with higher quality ratings in complementary and alternative medicine randomized controlled trials. Journal of Clinical Epidemiology 57:5, 438-446
CrossRef308
Asbjørn Hróbjartsson, Peter C Gøtzsche, Asbjørn Hróbjartsson. 2004. Placebo interventions for all clinical conditions. .
CrossRef309
Olesen, Jes, Diener, Hans-Christoph, Husstedt, Ingo W., Goadsby, Peter J., Hall, David, Meier, Ulrich, Pollentier, Stephane, Lesko, Lynna M., . (2004) Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine. New England Journal of Medicine 350:11, 1104-1110
Full Text310
Franz Porzsolt, Nicole Scholtz-Gorton, Nikola Biller-Andorno, Anke Thim, Karin Meissner, Irmgard Roeckl-Wiedmann, Barbara Herzberger, Renatus Ziegler, Wilhelm Gaus, Ernst Pöppel. (2004) Applying evidence to support ethical decisions: Is the placebo really powerless?. Science and Engineering Ethics 10:1, 119-132
CrossRef311
Franklin G. Miller. (2004) Sham surgery: An ethical analysis. Science and Engineering Ethics 10:1, 157-166
CrossRef312
Nikola Biller-Andorno. (2004) The use of the placebo effect in clinical medicine — ethical blunder or ethical imperative?. Science and Engineering Ethics 10:1, 43-50
CrossRef313
(2004) Another negative trial of manipulative treatment for back pain. Focus on Alternative and Complementary Therapies 9:1, 43-44
CrossRef314
Berit Sverdrup. (2004) Use Less Cosmetics—Suffer Less from Fibromyalgia?. Journal of Women's Health 13:2, 187-194
CrossRef315
F. Bloch, G. Abitbol, B. Nouvel, P. Ferlender, A. Tellier, . (2004) Placebo et effet placebo dans la prise en charge de la douleur: sa perception par les soignants. Douleur et Analgésie 17:1, 25-32
CrossRef316
Raúl de la Fuente-Fernández. (2004) Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease. Parkinsonism & Related Disorders 10:3, 125-127
CrossRef317
Jacek Spławiński, Jerzy Kuźniar. (2004) Clinical trials: active control vs placebo — What is ethical?. Science and Engineering Ethics 10:1, 73-79
CrossRef318
Joan Box. (2004) Placebos and the UK medical research council — and the consumer perspective. Science and Engineering Ethics 10:1, 95-101
CrossRef319
Claudio Sosa, Fernando Althabe, José M Belizán, Eduardo Bergel, Claudio Sosa. 2004. Bed rest in singleton pregnancies for preventing preterm birth. .
CrossRef320
Steve Stewart-Williams. (2004) The Placebo Puzzle: Putting Together the Pieces.. Health Psychology 23:2, 198-206
CrossRef321
Josep M.a. Argimon Pallás, Josep Jiménez Villa. 2004. Bases metodológicas de la investigación clínica y epidemiológica. , 8-15.
CrossRef322
Ananias C Diokno. (2004) Medical management of urinary incontinence. Gastroenterology 126, S77-S81
CrossRef323
Steve Stewart-Williams, John Podd. (2004) The Placebo Effect: Dissolving the Expectancy Versus Conditioning Debate.. Psychological Bulletin 130:2, 324-340
CrossRef324
Gunvor Bentung Lygre, Nils Roar Gjerdet, Lars Björkman. (2004) Patients' choice of dental treatment following examination at a specialty unit for adverse reactions to dental materials. Acta Odontologica Scandinavica 62:5, 258-263
CrossRef325
James P. Rathmell, Daniel B. Carr. (2003) The Scientific Method, Evidence-Based Medicine, and Rational Use of Interventional Pain Treatments. Regional Anesthesia and Pain Medicine 28:6, 498-501
CrossRef326
Douglas G Merrill. (2003) Hoffmanʼs Glasses. Regional Anesthesia and Pain Medicine 28:6, 547-560
CrossRef327
Hans-Christoph Diener. (2003) Placebo in headache trials. Cephalalgia 23:7, 485-486
CrossRef328
Dr Pierre, Dr Michel. (2003) ‘Hyperbaric oxygen therapy and cerebral palsy’. Developmental Medicine & Child Neurology 45:9, 646-647
CrossRef329
U Reuter, M Sanchez del Rio, JA Carpay, CJ Boes, SD Silberstein, . (2003) Placebo adverse events in headache trials: headache as an adverse event of placebo. Cephalalgia 23:7, 496-503
CrossRef330
Asbjørn Hróbjartsson, Peter C Gøtzsche. (2003) Unreliable analysis of placebo analgesia in trials of placebo pain mechanisms. Pain 104:3, 714-715
CrossRef331
D.D Price, J.L Riley, L Vase. (2003) Reliable differences in placebo effects between clinical analgesic trials and studies of placebo analgesia mechanisms. Pain 104:3, 715-716
CrossRef332
Daniel B. Carr, Leonidas C. Goudas. (2003) Burning Questions, Randomized Controlled Trials, and the Pain Doctorʼs Dilemma. Regional Anesthesia and Pain Medicine 28:4, 360-361
CrossRef333
Eric Leibing, Michael Pfingsten, Falk Leichsenring. (2003) Comment on: Molsberger AF, Mau J, Pawelec DB, Winkler J. Does acupuncture improve the orthopedic management of chronic low back pain? Pain 2002; 99:579–87. Pain 104:1-2, 425-426
CrossRef334
John C. Licciardone, Scott T. Stoll, Kimberly G. Fulda, David P. Russo, Jeff Siu, William Winn, Jon Swift. (2003) Osteopathic Manipulative Treatment for Chronic Low Back Pain. Spine 28:13, 1355-1362
CrossRef335
Alan Breen, Rosanna Breen. (2003) Back Pain and Satisfaction With Chiropractic Treatment: What Role Does the Physical Outcome Play?. The Clinical Journal of Pain 19:4, 263-268
CrossRef336
Lynton G. F. Giles, Reinhold Muller. (2003) Chronic Spinal Pain. Spine 28:14, 1490-1502
CrossRef337
A Eikermann, HC Diener. (2003) Effect of active treatment is lower when using placebo control in clinical trials on acute therapy of migraine. Cephalalgia 23:5, 344-347
CrossRef338
Olof Ekre, Henrik Norrsell, Peter Wahrborg, Tore Eliasson, Clas Mannheimer. (2003) Coronary Artery Disease 14:4, 323-327
CrossRef339
K Schmidt. (2003) The Science of the Placebo - Toward an Interdisciplinary Research Agenda. Focus on Alternative and Complementary Therapies 8:2, 279-280
CrossRef340
Sam Horng, Franklin G. Miller. (2003) Ethical framework for the use of sham procedures in clinical trials. Critical Care Medicine 31:Supplement, S126-S130
CrossRef341
Lars Noah. (2003) Challenges in the Federal Regulation of Pain Management Technologies. The Journal of Law, Medicine & Ethics 31:1, 55-74
CrossRef342
P. Calverley, E.T. Keating, M. Goldman, F. Casty. (2003) Conclusion lessons from the novel D2 dopamine receptor, β2-adrenoceptor agonist, Viozan™: chronic obstructive pulmonary disease and drug development implications. Respiratory Medicine 97, S71-S74
CrossRef343
W.Vaughn McCall, Ralph D'Agostino, Aaron Dunn. (2003) A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials. Sleep Medicine 4:1, 57-62
CrossRef344
G. Chvetzoff, I. F. Tannock. (2003) Placebo Effects in Oncology. JNCI Journal of the National Cancer Institute 95:1, 19-29
CrossRef345
R. J. Temple. (2003) Implications of Effects in Placebo Groups. JNCI Journal of the National Cancer Institute 95:1, 2-3
CrossRef346
Jorge G Burneo, Victor M Montori, Edward Faught. (2002) Magnitude of the placebo effect in randomized trials of antiepileptic agents. Epilepsy & Behavior 3:6, 532-534
CrossRef347
R. L. Bratton, D. P. Montero, K. S. Adams, M. A. Novas, T. C. McKay, L. J. Hall, J. G. Foust, M. B. Mueller, P. C. O'Brien, E. J. Atkinson, M. S. Maurer. (2002) Effect of 'Ionized' Wrist Bracelets on Musculoskeletal Pain: A Randomized, Double-Blind, Placebo-Controlled Trial. Mayo Clinic Proceedings 77:11, 1164-1168
CrossRef348
A Hróbjartsson, PC Gøtzsche. 2002. Placebo treatment versus no treatment. .
CrossRef349
George F. Longstreth, Douglas A. Drossman. (2002) New developments in the diagnosis and treatment of irritable bowel syndrome. Current Gastroenterology Reports 4:5, 427-434
CrossRef350
Anne Moyer, John W. Finney. (2002) Outcomes for untreated individuals involved in randomized trials of alcohol treatment. Journal of Substance Abuse Treatment 23:3, 247-252
CrossRef351
Lene Vase, Joseph L. Riley, Donald D. Price. (2002) A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99:3, 443-452
CrossRef352
Donald Moss, Jay Gunkelman. (2002) Task Force Report on Methodology and Empirically Supported Treatments: Introduction. Journal of Neurotherapy 6:4, 7-10
CrossRef353
Eugene V. Boisaubin. (2002) Practitioners and Clinical Trials. True to Your Patients - or Science?. Journal of General Internal Medicine 17:9, 738-739
CrossRef354
M. Robin DiMatteo, Patrick J. Giordani, Heidi S. Lepper, Thomas W. Croghan. (2002) Patient Adherence and Medical Treatment Outcomes. Medical Care 40:9, 794-811
CrossRef355
B. R. Levy, M. D. Slade, S. V. Kasl. (2002) Longitudinal Benefit of Positive Self-Perceptions of Aging on Functional Health. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 57:5, P409-P417
CrossRef356
Robert M. Bennett. (2002) A survey of symptoms and treatment of fibromyalgia. Current Rheumatology Reports 4:4, 285-285
CrossRef357
Moseley, J. Bruce, O'Malley, Kimberly, Petersen, Nancy J., Menke, Terri J., Brody, Baruch A., Kuykendall, David H., Hollingsworth, John C., Ashton, Carol M., Wray, Nelda P., . (2002) A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee. New England Journal of Medicine 347:2, 81-88
Full Text358
Horng, Sam, Miller, Franklin G., . (2002) Is Placebo Surgery Unethical?. New England Journal of Medicine 347:2, 137-139
Full Text359
Steven F. Moss, Irvin M. Modlin. (2002) Irritable Bowel and the Irritable Physician. Journal of Clinical Gastroenterology 35:Supplement, S68-S70
CrossRef360
(2002) The Management of Persistent Pain in Older Persons. Journal of the American Geriatrics Society 50:S6, 205-224
CrossRef361
Murad Alam, Nayomi E. Omura, Jeffrey S. Dover, Kenneth A. Arndt. (2002) Glycolic Acid Peels Compared to Microdermabrasion: A Right-Left Controlled Trial of Efficacy and Patient Satisfaction. Dermatologic Surgery 28:6, 475-479
CrossRef362
Raúl de la Fuente-Fernández, Michael Schulzer, A Jon Stoessl. (2002) The placebo effect in neurological disorders. The Lancet Neurology 1:2, 85-91
CrossRef363
Alvan R. Feinstein. (2002) Post-Therapeutic Response and Therapeutic ‘Style’. Journal of Clinical Epidemiology 55:5, 427-429
CrossRef364
Asbjørn Hróbjartsson. (2002) What are the main methodological problems in the estimation of placebo effects?. Journal of Clinical Epidemiology 55:5, 430-435
CrossRef365
Peter S. Staats. (2002) Implications of the Placebo Response for Interventional Pain Specialists. Neuromodulation: Technology at the Neural Interface 5:2, 69-71
CrossRef366
Peter A. Clark. (2002) Placebo Surgery for Parkinson's Disease: Do the Benefits Outweigh the Risks?. The Journal of Law, Medicine & Ethics 30:1, 58-68
CrossRef367
Caroline Smith, Caroline Crowther, Justin Beilby. (2002) Acupuncture To Treat Nausea and Vomiting in Early Pregnancy: A Randomized Controlled Trial. Birth 29:1, 1-9
CrossRef368
Cheryl Hawk, Cynthia R. Long, Robert Reiter, Charles S. Davis, Jerrilyn A. Cambron, Roni Evans. (2002) Issues in Planning a Placebo-Controlled Trial of Manual Methods: Results of a Pilot Study. The Journal of Alternative and Complementary Medicine 8:1, 21-32
CrossRef369
P. J. M. M. Toll, C. M. Corbey. (2002) Hoe werkzaam is een placebo?. Medisch-Farmaceutische Mededelingen 40:2, 29-30
CrossRef370
Mark A Moyad. (2002) Dietary supplements and other alternative medicines for erectile dysfunction What do I tell my patients?. Urologic Clinics of North America 29:1, 11-22
CrossRef371
Mark A Moyad. (2002) The placebo effect and randomized trials: analysis of conventional medicine. Urologic Clinics of North America 29:1, 125-133
CrossRef372
William E. Pelham, Betsy Hoza, David R. Pillow, Elizabeth M. Gnagy, Heidi L. Kipp, Andrew R. Greiner, Daniel A. Waschbusch, Sarah T. Trane, Joel Greenhouse, Lara Wolfson, Erin Fitzpatrick. (2002) Effects of methyphenidate and expectancy on children with ADHD: Behavior, academic performance, and attributions in a summer treatment program and regular classroom settings.. Journal of Consulting and Clinical Psychology 70:2, 320-335
CrossRef373
(2001) LiteratureWatch. Alternative and Complementary Therapies 7:6, 391-392
CrossRef374
Yiannis G. Papakostas, Michael D. Daras. (2001) Placebos, Placebo Effect, and the Response to the Healing Situation: The Evolution of a Concept. Epilepsia 42:12, 1614-1625
CrossRef375
(2001) Is the Placebo Powerless?. New England Journal of Medicine 345:17, 1276-1279
Full Text376
José Luis Rodriguez-Martin, José Manuel Barbanoj, TE Schlaepfer, Susana SC Clos, V Pérez, J Kulisevsky, A Gironelli, José Luis Rodriguez-Martin. 2001. Transcranial magnetic stimulation for treating depression. .
CrossRef377
Michelle M. Garrison, Dimitri A. Christakis. (2001) Infant Colic. Pediatric Case Reviews 1:1, 19-24
CrossRef378
Emanuel, Ezekiel J., Miller, Franklin G., . (2001) The Ethics of Placebo-Controlled Trials — A Middle Ground. New England Journal of Medicine 345:12, 915-919
Full Text379
John Z. Sadler, Bill Fulford. (2001) Editors’ introduction: on becoming and constraining science. Current Opinion in Psychiatry 14:5, 483-484
CrossRef380
David P.J. Osborn. (2001) Placebos and research ethics: an absolute dilemma?. Current Opinion in Psychiatry 14:5, 507-511
CrossRef381
Arthur P. Grollman. (2001) Need for Scholarly, Objective Inquiry into Alternative Therapies. Academic Medicine 76:9, 864-865
CrossRef382
Helen Pearson. (2001) Great expectations. news@nature
CrossRef383
David J Rowbotham. (2001) Endogenous opioids, placebo response, and pain. The Lancet 357:9272, 1901-1902
CrossRef384
Bailar, John C. III, . (2001) The Powerful Placebo and the Wizard of Oz. New England Journal of Medicine 344:21, 1630-1632
Full Text385
Wang Bao-en. (2001) Ademetionine 1,4 Butanedisulphonate vs Traditional Chinese Medicine for the Treatment of Hepatocellular Jaundice Complicating Chronic Viral Hepatitis. Clinical Drug Investigation 21:11, 765-773
CrossRef
